Archive for August, 2020

$DRIO New Blood Test Could Provide Timely Detection of Lung Transplant Rejections

Persistent transplant failure can be hazardous. Realizing this failure as early as possible is therefore very vital in achieving the best possible patient outcomes. The good news is that a new test has been discovered to help detect the symptoms of this condition in lung transplants. The test detects the signs before any outward symptoms start showing themselves, enabling physicians to act urgently to protect the lives of patients.

Detecting and treating organ transplant failure using the blood sample test

The test was discovered and developed by the Laboratory of Organ Transplant Genomics in the Cardiovascular Branch of the National Heart, Lung, and Blood Institute (“NHLBI”). For the test to work, it requires a simple blood sample to detect early lung transplant failure. The test is also believed to have the potential to be used to identify other organ transplant failures by the researchers.

A blood sample is taken from a patient’s arm and put in a machine capable of sorting the DNA fragments in a blood sample. Computer analysis is then used to examine the number of DNA cells from the patient and those from the donor and if the donor’s DNA fragments are more than those of the patient, the risk of transplant failure is elevated.

The test was conducted on a sample of 106 patients for the first three months after being subjected to lung transplants. It was discovered that those patients who had a higher number of donor DNA fragments in their blood were six times more likely to have organ transplant rejection. Even without showing the outward signs, organ transplant failure was probably going to be high.

However, once the failure is discovered early through this blood sample test, physicians could increase the dosage of anti-rejection drugs. Furthermore, they could also add other new agents in medicine to reduce tissue inflammation in patients. The doctors could also take other intervention measures to ensure that they stop or lower the progression rate.

The test has been a significant and essential breakthrough in the medical field because lung transplants have the lowest survival rates in all organ transplant surgeries. Initially, the sole way to detect if the patient was undergoing rejection before the outward signs could be seen was by invasive-like lung biopsy. However, this method was not reliable and sensitive enough to detect the extremity of what the patient was undergoing. It even led to more organ transplant failures and fatalities in lung transplant patients.

Such breakthroughs, and others pioneered by entities like DarioHealth Corp. (NASDAQ: DRIO), are helping to give hope to lots of patients who may have given up of ever getting a new lease of life after being diagnosed with potentially life-threatening conditions.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Tuesday, August 18th, 2020 Uncategorized Comments Off on $DRIO New Blood Test Could Provide Timely Detection of Lung Transplant Rejections

$DRIO Beats Street Q2 Revenue Estimates by 20% and Reveals Late Stage, Virtual Healthcare, B2B2C Sales Pipeline

  • DarioHealth Corp. reported its second quarter financial results Aug. 12, showing a revenue increase on a quarter-to-quarter basis, as well as gross profit increases of 95 percent and 60 percent on year-over-year quarterly and six-month measures, respectively
  • CEO Erez Raphael recently appeared on Fox Business news forum “The Claman Countdown” to discuss the company’s health and the state of the telemedicine industry amid reports of high-value M&A activity
  • Telemedicine has gained significant popularity as a means of maintaining health standards while reducing or eliminating the risk of virus transmission during the ongoing COVID-19 pandemic
  • U.S. President Donald Trump recently signed measures designed to make emergency authorization for insurance reimbursements for telehealth services more permanent beyond the duration of the pandemic, and many private insurers are beginning to follow suit
  • DarioHealth has gained market attention as it has racked up successes in advancing its remote health monitoring platform for diabetes and hypertension patients where it is commercially available in the United States, Canada, the United Kingdom, Europe and Australia after clearing regulatory hurdles
  • The company announced its first two remote patient monitoring agreements in North America in June, followed by an agreement covering the United Kingdom and Ireland in July

The innovative energy driving the health technology company DarioHealth (NASDAQ: DRIO) has generated a series of successes for the small-cap company, and DarioHealth is anticipating additional developments in the coming weeks that may help the company continue to grow and mature, according to CEO Erez Raphael in the company’s just-released Q2 financial statement.

“The COVID-19 pandemic has accelerated our ongoing transformation to a business-to-business-to-consumer (B2B2C) digital therapeutics leader,” Raphael stated in the Aug. 12 statement (http://ibn.fm/clts7). “We advanced late-stage discussions with health plans and self-insured employers, who we believe recognize how our industry-leading user engagement and satisfaction metrics lead to improved health for their member and employee populations. … We believe that we are poised to announce new and potentially transformational agreements in the next few weeks.”

DarioHealth recorded a 7.2 percent sequential increase in revenues from the first to second quarter and a 95 percent year-over-year increase in quarterly gross profit due principally to an increase in membership revenues and a decrease in product costs during the second quarter, according to the financial report.

On a six-month reporting measure, the company saw revenues decrease 11.3 percent year-over-year as part of its transformation from a direct-to-consumer operation, but gross profits increased by 60 percent as a result of the same processes, resulting in $1.4 million in added profits for the first half of 2020.

Fox Business news forum “The Claman Countdown” recognized DarioHealth’s growing success in an Aug. 7 segment that featured Raphael’s perspective about M&A activity within the telemedicine sector and DarioHealth’s strong trending in the marketplace at the time (http://ibn.fm/hWIOl).

“We are in a very, very special period of time when we see a huge transformation of the space,” Raphael told interviewer Liz Claman.

Raphael added that DarioHealth has been “part of the digital health and digital therapeutics (sector) for the last 10 years and we have been there for a long time building very smart technologies, and I can tell you the last five months are big in terms of the transformation that we feel. A lot of bills that we were trying to get for a lot of fields of science, we feel we are getting there and this is a very good signal from the White House that understands the importance of virtualization of the health care industry.”

DarioHealth’s CEO was responding to news that U.S. President Donald Trump had signed an executive order directing Centers for Medicare and Medicaid Services (“CMS”) officials to make some emergency telehealth regulatory reforms permanent so that they will remain in place even beyond the pandemic, although keeping some other emergency measures in place, such as enabling patients to get coverage for telehealth visits at home, will require Congressional approval (http://ibn.fm/0RdQa).

The use of telemedicine services has surged during the COVID-19 pandemic as patients and medical providers have worked to maintain standard of health services through remote, virtual platforms to minimize the risk of spreading infection. Medicare’s fee-for-service telehealth claims rose from 13,000 per week before the pandemic to nearly 1.7 million by the end of April, and claims to private insurers have grown 4,347 percent year-over-year (http://ibn.fm/UbzRt).

Trump’s executive action also directed the Department of Health and Human Services (“HHS”) to begin a payment program designed to make government healthcare program reimbursements more consistent to rural community hospitals as they demonstrate quality care, and directed the Departments of Agriculture (“USDA”), HHS and the Federal Communications Commission (“FCC”) to form a task force designed to improve broadband infrastructure in rural communities for telehealth providers.

“Today I’m taking action to ensure telehealth is here to stay,” Trump said in announcing the orders.

DarioHealth’s CEO noted that insurance companies in the private sector are also moving to adopt such measures, building a framework by which telehealth services can be recognized as vital and quality-focused so that providers and patients may utilize technological tools under a rubric that authorizes reimbursements.

DarioHealth’s Remote Patient Monitoring (“RPM”) digital therapeutics platform transmits patient information to physicians and also delivers occasional “nudges” to patients when its automated programming recognizes a need (http://ibn.fm/dsBme). The RPM is specifically designed for diabetes and hypertension patients, with the potential for monitoring and helping to manage a wide array of chronic conditions in the future.

The company’s blood glucose monitoring system has U.S Food and Drug Administration (“FDA”) clearance and has similarly been approved by European, Canadian and Australian regulatory agencies that have allowed it to become commercially available in the United States, Canada, the United Kingdom and Ireland, Germany, Italy, and Australia while continuing to expand into new geographic markets and to support additional chronic conditions.

For more information, visit the company’s website at www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Tuesday, August 18th, 2020 Uncategorized Comments Off on $DRIO Beats Street Q2 Revenue Estimates by 20% and Reveals Late Stage, Virtual Healthcare, B2B2C Sales Pipeline

$CNPOF Announces Q1 2021 Financial Results

Canopy Rivers (TSX: RIV) (OTC: CNPOF), today released its unaudited condensed interim consolidated financial statements and management’s discussion and analysis (“MD&A”) for the three months ended June 30, 2020 (“Q1 2021”). “This quarter, we made a strategic investment in Dynaleo, a cannabis gummies manufacturer that we believe is well-positioned to help Canada’s licensed producers and brands catch up to consumer demand for the gummy product format,” Narbé Alexandrian, president and CEO of Canopy Rivers, stated in the news release. “We also continued to work closely with our portfolio companies to help resolve some of the unique macroeconomic challenges that emerged inside and outside of the cannabis sector. While PharmHouse faces some immediate challenges, we continue to believe that it has the potential to become a key component of the Canadian supply chain for low-cost, high-quality cannabis, especially as the value segment of dry flower becomes more prominent.”

To view the full press release, visit http://cnw.fm/7XxJY

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies across various segments of the cannabis value chain. Canopy Rivers believes that bringing together people, capital and ideas raises the potential of the entire cannabis industry. By leveraging its industry insights, in-house expertise, and thesis-driven approach to investing, Canopy Rivers aims to provide shareholders with exposure to specialized and disruptive cannabis companies. The company’s mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with its portfolio, Canopy Rivers is helping build the cannabis industry of tomorrow, today. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/CNPOF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Friday, August 14th, 2020 Uncategorized Comments Off on $CNPOF Announces Q1 2021 Financial Results

$YGYI Receives Additional Notification Letters Regarding Non-Compliance with Nasdaq Listing Rule 5250(c)(1)

Youngevity International (NASDAQ: YGYI), a leading multichannel lifestyle company operating in three distinct business segments, today announced its August 12 receipt of an additional notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the company is not in compliance with Nasdaq Listing Rule 5250(c)(1). According to the update, this is due to its quarterly report on Form 10-Q for the quarter ended June 30, 2020, not having been filed on a timely basis with the Securities and Exchange Commission. The company also received notification, on August 11, stating that the Nasdaq staff had determined to grant an exception to enable the company to regain compliance with Nasdaq Listing Rule 5250(c)(1). On April 2 and May 14, 2020, the company received notification that it did not comply with Nasdaq’s filing requirements set forth in the rule because it had not filed its Form 10-K for the year ended December 31, 2019 and Form 10-Q for the period ended March 31, 2020, respectively. Youngevity’s management is working diligently to complete the Form 10-K, March 31 Form 10-Q and June 30 Form 10-Q and intends to file each report as soon as practicable.

To view the full press release, visit http://nnw.fm/wsX7q

About Youngevity International, Inc.

Youngevity International is a multichannel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct-selling enterprise. The company features a multi-country selling network and has assembled a virtual Main Street of products and services under one corporate entity. YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. For investor information, please visit www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://nnw.fm/YGYI

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, August 14th, 2020 Uncategorized Comments Off on $YGYI Receives Additional Notification Letters Regarding Non-Compliance with Nasdaq Listing Rule 5250(c)(1)

$BHAT Announces First Half Year of 2020 Unaudited Financial Results

XIAMEN, ChinaAug. 14, 2020 — Blue Hat Interactive Entertainment Technology (“Blue Hat” or the “Company”) (NASDAQ: BHAT), a producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced its unaudited financial results for the six months ended June 30, 2020.

First Half Year of 2020 Financial Highlights

  • Total revenues decreased by 34.9% for the six months ended June 30, 2020 to US$4.9 million.
  • Gross profit decreased by 30.8% for the six months ended June 30, 2020 to US$3.7 million.
  • Income from operations decreased by 50.8% for the six months ended June 30, 2020 to US$1.6 million.
  • Net income decreased by 58.8% for the six months ended June 30, 2020 to US$1.3 million.

“The outbreak of COVID-19 since the beginning of 2020 has adversely impacted the global economy and our financial performance in the first half year was negatively affected as a result of the suspension of the entire industry. With daily life in China gradually returning to normal since April, our business related to education industry ramped up during the period,” said Mr. Xiaodong Chen, Chief Executive Officer of Blue Hat, “I’m pleased that our thriving smart education business line made a significant addition to our portfolio. ‘AR Immersive Classes’ (‘ARIC’), integrated with physical exercises in terms of AR-based educational content and products, targets children between three and six years old. Interactive education combines teaching with entertainment, inspiring kids with imagination and critical thinking. We build Direct-to-Consumer social content marketing channels via short videos and live streaming to increase our brand awareness, and broaden our market reach. Looking forward, we intend to continue to explore both in-house development and strategic investment opportunities to strengthen our pipeline of toy and game content and maximize shareholder value.”

Recent Developments

  • Blue Hat announced in January 2020 that its AR child abuse prevention course would be introduced in 25 preschools in Tong’an District, Xiamen City as a compulsory part of the curriculum for children before they graduate from kindergarten.
  • In February 2020, Blue Hat announced a new suite of smart educational products “AR Immersive Classes” (“ARIC”), which includes “Smart Screen Immersive Education Classes”, “Smart Immersive Cognitive Education Classes” and “Smart Immersive Physical Education Classes.”, and upgrades System for Evaluating Developmental Progress of Preschool Students in China.
  • In March 2020, Blue Hat’s “Interactive System Based on Light Intensity Recognition” received U.S. patent with the number US 10,512,836 B2 from the United States Patent and Trademark Office.
  • In May 2020, Blue Hat announced that it has signed a three-year partnership with smart education service provider, Sutesen Information Technology Ltd., to expand Blue Hat’s Smart Immersive Education Classes, or ARIC, in Guangxi province, China. The partnership aims to commercially launch ARIC in up to 1,000 Guangxi preschools in three years.
  • In June 2020, Blue Hat announced that it has partnered with Xiamen Xing Meng Wei Lai Culture Media Co. LTD, a leading Chinese multi-channel network and internet content development agency, to build Direct-to-Consumer social content marketing channels via short videos and live streaming.
  • In July 2020, Blue Hat entered into a Securities Purchase Agreement with two accredited institutional investors to sell senior secured convertible notes of the Company in a private placement to the investors, in the aggregate principal amount of $3,262,000, together with the issuance of warrants to acquire up to 784,000 ordinary shares of the Company for an aggregate cash purchase price of $2,800,000 (reflecting an original issue discount of $462,000).

First Half 2020 Results

Total revenues were $4.9 million for the six months ended June 30, 2020, a decrease of $2.6 million, or 34.9%, from $7.5 million for the same period ended June 30, 2019. The overall decrease was primarily attributed to the fewer sales of interactive toys (game series) during the period, partially offset by revenue from ARIC, which was launched to the market this year.

Gross profit was $3.7 million for the six months ended June 30, 2020, a decline of $1.6 million, or 30.8%, from $5.3 million for the same period ended June 30, 2019. Gross profit margin was 75.2% for the six months ended June 30, 2020, compared to 70.8% for the same period of 2019. Research and development expenses of mobile games recorded in Cost of Sales are fully amortized this February, consequently, gross profit ratio increased by 4.4%.

Operating expenses were $ 2,032,696 for the six months ended June 30, 2020, an increase of $47,752, or 2.4%, from $1,984,944 for the same period ended June 30, 2019. This increase was mainly due to the increase of general and administrative expenses amounted to $221,638, offset by the decrease of selling expense of around $119,705. Fixed cost increased during the first half of 2020 mainly due to the amortization of newly incurred rental cost and software patents. Legal expenses accounted for an obvious growth of general and administrative expenses in connection with our recent financing.

Income from operations was $1.6 million for the six months ended June 30, 2020, a decrease of $1.7 million, or 50.8%, from $3.3 million for the same period ended June 30, 2019.

Net income attributable to ordinary shareholders was $1.3 million for the six months ended June 30, 2020, compared with $3.1 million for the same period ended June 30, 2019. or $0.04 and $0.09 per basic and diluted share respectively.

Cash and Cash Equivalents

As of June 30, 2020, BHAT maintained strong cash resources of cash and cash equivalents totaling $11.4 million, compared with $10.5 million by the ended of December 31, 2019.

About Blue Hat

Blue Hat Interactive Entertainment Technology is a producer, developer and operator of AR interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The Company’s interactive entertainment platform creates unique user experiences by connecting physical items to mobile devices, which creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery.  Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users. For more information, please visit the Company’s investor relations website at http://ir.bluehatgroup.com.  The Company routinely provides important information on its website.

Forward-Looking Statements 

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the Company’s SEC filings. These risks and uncertainties could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements.

Contacts:

Lexie Zhang
Blue Hat Interactive Entertainment Technology
Phone: +86 (592) 228-0010
Email: ir@bluehatgroup.net

 

 

 

BLUE HAT INTERACTIVE ENTERTAINMENT TECHNOLOGY AND SUBSIDIARIES

UNAUDITED CONSOLIDATED BALANCE SHEETS

June 30,

December 31,

ASSETS

2020

2019

CURRENT ASSETS

Cash and cash equivalents

US$

11,372,626

US$

10,478,587

Accounts receivable, net

14,420,292

13,631,359

Other receivables, net

12,972,825

13,182,529

Prepayments, net

277,376

299,577

Inventories

249,563

125,264

Restricted cash

5,000,000

Total current assets

39,292,682

42,717,316

PROPERTY AND EQUIPMENT, NET

4,417,195

2,324,823

OTHER ASSETS

Prepayments

4,660,489

4,425,849

Operating lease, right-of-use asset

501,136

679,850

Intangible assets, net

6,423,487

6,758,316

Long-term investments

1,702,098

1,727,301

Deferred tax assets

188,872

182,234

Total other assets

13,476,082

13,773,550

Total assets

US$

57,185,959

US$

58,815,689

LIABILITIES AND SHAREHOLDERS’ EQUITY

CURRENT LIABILITIES

Short-term loans – banks

1,963,415

5,819,787

Current maturities of long-term loans – third
party

51,915

77,493

Accounts payable

1,420,706

293,985

Other payables and accrued liabilities

3,278,340

3,628,809

Other payables – related party

252,989

21,341

Operating lease liabilities-current

264,903

313,460

Customer deposits

3,573

Taxes payable

4,264,275

3,525,153

Total current liabilities

11,500,116

13,680,028

OTHER LIABILITIES

Operating lease liability

255,190

372,051

Long-term loans – third party

13,328

Total other liabilities

255,190

385,379

Total liabilities

11,755,306

14,065,407

COMMITMENTS AND CONTINGENCIES

Total shareholders’ equity

Ordinary shares, US$0.001 par value, 50,000,000
shares authorized, 35,141,114 shares issued and
outstanding as of June 30, 2020,  35,141,114 shares
issued and outstanding as of December 31, 2019

35,141

35,141

Additional paid-in capital

20,771,849

20,771,849

Statutory reserves

1,289,765

1,289,765

Retained earnings

25,391,957

24,132,194

Accumulated other comprehensive income
(loss)

(2,058,059)

(1,478,667)

Total shareholders’ equity

45,430,653

44,750,282

Total liabilities and shareholders’ equity

US$

57,185,959

US$

58,815,689

 

 

 

 

BLUE HAT INTERACTIVE ENTERTAINMENT TECHNOLOGY AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

For the Three Months ended June 30,

2020

2019

REVENUES

US$

2,611,204

 US$

3,176,566

Interactive toys – animation series

(148)

11,248

Interactive toys – game series

2,046,625

2,251,849

Mobile games

564,727

913,469

COST OF REVENUES

(634,473)

(953,732)

GROSS PROFIT

1,976,731

2,222,834

OPERATING EXPENSES

Selling

(117,549)

(207,263)

General and administrative

(1,057,108)

(650,605)

Research and development

(69,128)

(96,148)

Total operating expenses

(1,243,785)

(954,016)

INCOME FROM OPERATIONS

732,946

1,268,818

OTHER INCOME (EXPENSE)

Interest income

107,507

32

Interest expense

(51,053)

(18,759)

Other finance expenses

47,581

(724)

Other (expense) income, net

2,328

(105,621)

Total other income, net

106,363

(125,072)

INCOME BEFORE INCOME TAXES

839,309

1,143,746

PROVISION FOR INCOME TAXES

(338,919)

(55,447)

NET INCOME

500,390

1,088,299

OTHER COMPREHENSIVE INCOME (LOSS)

Foreign currency translation adjustment

25,968

31,760

COMPREHENSIVE INCOME

US$

526,358

 US$

1,120,059

WEIGHTED AVERAGE NUMBER OF
ORDINARY SHARES

Basic and diluted

35,141,114

33,000,000

EARNINGS PER SHARE

Basic and diluted

US$

0.01

 US$

0.03

 

 

BLUE HAT INTERACTIVE ENTERTAINMENT TECHNOLOGY AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

For the Six Months ended June 30,

2020

2019

REVENUES

US$

4,854,862

 US$

7,453,379

Interactive toys – animation series

54

89,391

Interactive toys – game series

3,701,861

6,116,883

Mobile games

1,152,947

1,247,105

COST OF REVENUES

(1,203,962)

(2,176,756)

GROSS PROFIT

3,650,900

5,276,623

OPERATING EXPENSES

Selling

(290,699)

(410,404)

General and administrative

(1,596,818)

(1,375,180)

Research and development

(145,179)

(199,360)

Total operating expenses

(2,032,696)

(1,984,944)

INCOME FROM OPERATIONS

1,618,204

3,291,679

OTHER INCOME (EXPENSE)

Interest income

107,884

502

Interest expense

(123,660)

(65,507)

Other finance expenses

(10,168)

(1,881)

Other (expense) income, net

20,862

(3,230)

Total other income, net

(5,082)

(70,116)

INCOME BEFORE INCOME TAXES

1,613,122

3,221,563

PROVISION FOR INCOME TAXES

(353,359)

(161,346)

NET INCOME

1,259,763

3,060,217

OTHER COMPREHENSIVE INCOME (LOSS)

Foreign currency translation adjustment

(579,392)

12,269

COMPREHENSIVE INCOME

US$

680,371

 US$

3,072,486

WEIGHTED AVERAGE NUMBER OF
ORDINARY SHARES

Basic and diluted

35,141,114

33,000,000

EARNINGS PER SHARE

Basic and diluted

US$

0.04

 US$

0.09

 

Friday, August 14th, 2020 Uncategorized Comments Off on $BHAT Announces First Half Year of 2020 Unaudited Financial Results

$POAI Announces Q2 2020 Results, Business Update and DojoLIVE! Interview

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Thursday released financial results for the quarter ended June 30, 2020 and provided a business update. “During the second quarter we reached a major milestone in our journey towards full commercialization with the first sale of our novel ovarian cancer cell media to a top-rated medical university in New England,” Dr. Carl Schwartz, Predictive Oncology CEO, stated in the news release. “This sale serves as a solid proof point of our mission and is a significant achievement towards improving healthcare outcomes for cancer patients. Our unique media significantly expands the number of ovarian cancer cell types that can be studied representing nearly 95% of all ovarian cancers, many of which have never been cultured before now, and reduces waste in cancer research.”

In addition, the company today announced that Mark Collins, Ph.D., chief innovation officer of its Helomics subsidiary, recently appeared on DojoLIVE!, an engaging podcast and interview forum that brings together technology, business and thought leaders from a wide range of software companies and startups. The broadcast is titled “Can We Cure Cancer With Artificial Intelligence?” and is available via the DojoLIVE! website for on-demand viewing. During the interview, Collins discussed a passion for applying science to build high-tech products and services that impact the search for new medicines and the unique positioning of Helomics to deliver on this goal.

To view the full press release, visit http://ibn.fm/ol0FR and http://ibn.fm/aIrPK

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drives the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions by providing an evidence-based roadmap for therapy. In addition to its proprietary precision-oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, August 14th, 2020 Uncategorized Comments Off on $POAI Announces Q2 2020 Results, Business Update and DojoLIVE! Interview

$WTER Announces Record Q1 Revenue of $14.2M

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, on Thursday announced record revenue of $14.2 million for the fiscal first quarter ended June 30, 2020, reflecting an approximate 40% year-over-year and 18% sequential increase. The Alkaline Water Company also reported a 57.3% improvement of earnings per share compared to the prior-year quarter and indicated that July’s purchase orders were the second-highest of any month in the company’s history. “Fiscal 2021 is off to a solid start with strong momentum across all our lifestyle brands. We delivered record fiscal Q1 revenue of $14.2 million and showed operational discipline with expenses down 5% year-over-year. During the last six months, we have performed exceptionally well, and according to Nielsen data, we outperformed the value-add water category by approximately 12% on a dollar sales basis and 16% on a unit basis. Our operational excellence during the pandemic is creating significant goodwill with existing channel partners, who are showing a stronger commitment to our brands, especially our single-serve, aluminum, and flavored water offerings. Alkaline88 remains one of the top-selling brands in the value-added water category,” Richard A. Wright, president and chief executive officer of The Alkaline Water Company, stated in the news release. “According to recent trade data, Alkaline88 was one of the two brands that showed double-digit growth as the category briefly turned negative in early July. With a solid sales pipeline in new and existing trades, our robust lineup of innovative products, and growing momentum in our lifestyle brands, we are excited about the opportunities in fiscal 2021 and beyond.”

To view the full press release, visit http://cnw.fm/4Gpzc

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88(R) delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label “Clean Beverage.” Quickly being recognized as a growing lifestyle brand, Alkaline88(R) launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused(TM) flavored water is available in seven unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested full-spectrum hemp salves, balms, lotions, essential oils, and bath salts, along with broad-spectrum hemp beverage shots, powder packs, oil tinctures, capsules, and gummies. To purchase A88CBD(TM) products online, visit www.A88CBD.com. To learn more about The Alkaline Water Company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Friday, August 14th, 2020 Uncategorized Comments Off on $WTER Announces Record Q1 Revenue of $14.2M

$PBIO Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device

  • Pressure BioSciences develops and sells pressure-based instruments and consumables to the global life sciences, food and beverage, and other large research markets
  • Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”)
  • The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market, which is exponentially larger than the research products market where the Company currently transacts business
  • The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important and popular consumable to date
  • PBI has seen revenue from consumables steadily increase in recent years and double in just four years. The new patent provides greater security for its business model as well as potential for more explosive growth
  • Recent publications from highly regarded scientists in Australia, China, and the U.S., cite the important use of PCT and the PCT MP in critical areas of scientific research, including cancer and COVID-19 research

Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform solutions to the worldwide Life Sciences and other industries, has been awarded a pivotal U.S. patent for “Sample Preparation Devices and Methods” (http://nnw.fm/fIYe6).

With this new patent, the Company continues to expand its already significant intellectual property ownership, which now includes 25 issued patents.

Pressure BioSciences’ unique pressure cycling technology (“PCT”) systems are comprised of two major, interdependent components: the pressure cycling instrument and the consumable that contains and delivers the cycled pressure to the sample. The newly patented PCT MicroPestle (“MP”) is a critical addition to the Company’s impressive instruments and consumables product line.

The PCT MP is the Company’s most important and popular consumable to date, having a unique construction that seals and protects the sample while flexing to transfer immense pressures to the important samples being processed inside the MP tube. This, in turn, facilitates homogenization and precise physical and chemical preparation of biological samples, sometimes very small and hard-to-process specimens such as needle biopsies, small suspensions of cells, and laser micro-dissected tissue sections.

The PCT MicroPestle is designed with inert fluoropolymer material, which maintains stability for the sample as it experiences significant temperature fluctuations. The PCT MP also provides powerful resistance to aggressive chemicals. Extremely low surface binding characteristics enable the PCT MP to preserve and maximize the availability of each sample’s precious molecules, which often include important biomarkers for disease diagnosis or critical prognostic decisions regarding treatment selection and guidance.

Recent publications cite the use of PCT and the PCT MP in cancer and COVID-19 research, citing the use of the Company’s products in their studies to develop better methods for the detection, prevention, and cure of infectious diseases.

Prospective Financial Impact of the New Patent

With the PCT MP, Pressure BioSciences inches all that much closer to entering the clinical market, which has exponentially larger potential than the research market, where the Company currently transacts business. With just one proven clinical application of PCT and the PCT MP, Pressure BioSciences will have enormous potential for revenue.

PCT instruments tend to heavily impact revenue up front, while consumables continue to provide revenue potential throughout the life of the instrument. Pressure BioSciences has seen revenue from consumables steadily increase in recent years and double in just the past four years, from $150K in 2015 to $260K in 2017 and then $300K in 2019. The new patent provides even more security for this kind of growth and potential for more explosive growth.

Several high-profile labs in pharma, biotech, government, and academia routinely use the PCT MP. Publications about the capabilities of PCT MP are making their way into circulation and garnering attention. This is particularly true for the processing of minute cancer biopsy tissues and other small specimens where the options for a high-quality processing method are few and far between.

Worldwide Customer Demand

According to Ms. Roxana McCloskey, Pressure BioSciences’ Global Director of Sales and Marketing, the PCT MP is already used in prominent studies such as the one conducted by Professor Phil Robinson and his team at the Children’s Medical Research Institute in Australia (processing 70,000 tumor samples, looking for prognostic and diagnostic markers in cancer) and the one run by Dr. Tiannan Guo and his team at Westlake University in China (studying thyroid cancer and COVID-19).

The PCT MP is also a critical part of the innovative laser microdissection tumor processing workflow developed by Dr. Tom Conrads of the Inova Health System in the U.S. This important new tumor processing method promises the potential for significant improvements in the clinical management of most solid tumor cancers. Dr. Conrads’ novel workflow is the basis of Pressure BioSciences’ major co-marketing collaboration recently announced with Leica Microsystems (a Danaher company).

“It is clear why we see this award of the PCT MP patent as a critical milestone in securing our pivotal intellectual property around the PCT system, and another important driver toward accelerated adoption of PCT in biological sample preparation markets. We expect to take full advantage of this opportunity and further boost our sales,” Ms. McCloskey said.

Dr. Alexander Lazarev, Pressure BioSciences’ Chief Scientific Officer, added: “This long-anticipated patent is an exciting endorsement of our efforts to transform biological sample preparation. This powerful new dimension to our patent protected portfolio should help us to secure and accelerate the growth of our business.”

For more information, visit the company’s website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, August 14th, 2020 Uncategorized Comments Off on $PBIO Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device

$NETE Announces Q2 2020 Financial Results

Net Element (NASDAQ: NETE), a global technology and value-added solutions group that supports electronic payments acceptance in a multichannel environment including point-of-sale (“POS”), e-commerce and mobile devices, on Thursday reported its financial results for the second quarter ended June 30, 2020. “The COVID-19 pandemic continued to negatively impact our financial results during the second quarter of this year. Our ability to adapt quickly by implementing safety protocols to protect our employees has been successful so far, and we are happy to report we have had zero cases of COVID-19 among our employees. We also implemented cost-cutting initiatives while boosting support for our merchants through e-commerce solutions, contactless payment alternatives and online food ordering for restaurants,” Oleg Firer, CEO of Net Element, stated in the news release. “We continue working diligently to increase shareholder value as we continue to work toward the proposed merger with Mullen Technologies Inc.”

To view the full press release, visit http://ibn.fm/pjApc

About Net Element, Inc.

Net Element operates a payments-as-a-service transactional and value-added services platform for small to medium enterprises (“SMEs”) in the U.S. and selected emerging markets. In the U.S., it aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, the company’s cloud-based restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omnichannel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest-growing companies in North America on Deloitte’s 2017 Technology Fast 500(TM). In 2017, the company was recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Friday, August 14th, 2020 Uncategorized Comments Off on $NETE Announces Q2 2020 Financial Results

$ICLK Featured on The Watch List with Nicole Petallides

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that Sammy Hsieh, the company’s chairman and co-founder, appeared, on August 13, as a featured guest on TD Ameritrade Network’s The Watch List with veteran news anchor Nicole Petallides. During the interview, Sammy shared how iClick is revolutionizing digital marketing in China by helping many of the world’s largest companies not only effectively identify and interact with consumers online, but also integrate online-to-offline information to unlock the huge potential of the smart retail market. Hsieh also discussed how brands are increasingly focusing on China as it recovers from the COVID-19 downturn, helping propel iClick’s revenue to record heights and sending its stock price soaring over the past 6 months.

To view the full press release, visit http://nnw.fm/xgC2x

About iClick Interactive Asia Group Limited

iClick Interactive Asia Group is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, iClick’s proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in ten locations worldwide, including Asia and Europe.

For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://nnw.fm/ICLK

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, August 14th, 2020 Uncategorized Comments Off on $ICLK Featured on The Watch List with Nicole Petallides

$GNPX How Africa Plans to Create Its Own Medical Technology

Some technological advancements, such as biomedical engineering, can be used in saving lives because the biomedical engineering field draws knowledge from different disciplines such as computer science, public health, clinical practice and biomedical sciences.

The information from these four areas has been combined to design medical devices for proper diagnosis and treatment of diseases.

In Africa, most of the medical equipment is imported since they cannot be produced locally, yet. It is also challenging to use some of the machines since the medical staff lack the knowledge to operate them. However, it is high time that Africa develops and produces its own medical tools, and experienced biomedical engineers are needed for these innovations to be successful. Fortunately, several African universities have launched the African Biomedical Engineering Consortium to spearhead these innovations.

Need for skill development

Biomedical engineers alone cannot make Africa a world leader in the innovation of medical devices. They need other fundamental structures such as equipped laboratories for prototyping and experimenting. Furthermore, the required regulations must be put in place to ensure the safety of the equipment and intellectual property rights. However, the Consortium’s focus is to produce individuals who can bring innovation into the workplace.

For the last five years, the Consortium has brought together established and new biomedical engineering programs in several African universities. These programs are to help the continent develop the required equipment in the health sector. The network is growing stronger as some members have opted to pay extra attention to transferring skills and knowledge across all participating institutions.

Additionally, a capacity-building project has been launched to help train postgraduate students in biomedical courses. Six African universities have been selected to ensure this project kicks off immediately. The selected students will be offered a full scholarship to enable them to finish their courses. The initiative focuses on building techniques that will address African needs. It will shift its core by engaging learners in programs that will arise from local realities such as:

  • Creating prosthetic limbs for landmine victims
  • Using mobile phones with custom-made applications as diagnostic tools in rural areas
  • Developing equipment that uses 3D visualization for analyzing the body’s anatomy.

Establishing Academic Foundations

Training more scholars is not enough to make Africa develop its own medical devices. They need academicians who can maneuver the interdisciplinary setting necessary to develop technological results to healthcare problems. The project therefore also aims at supporting other academics who want to improve their technique.

The project is allowing African scholars to travel to any partnering institution to enhance their skills further. It is also providing another opportunity for African universities to harmonize their biomedical engineering curricula and also have benchmarks on each other. By doing all those, Africa can develop their own medical devices to improve the health sector.

Industry watchers say biomedical companies like Genprex Inc. (NASDAQ: GNPX) would be more than willing to support such undertakings in any way they can in order to make better healthcare a reality for nations across the globe.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, August 14th, 2020 Uncategorized Comments Off on $GNPX How Africa Plans to Create Its Own Medical Technology

$MEDS to Present at LD Micro’s LD 500 Virtual Conference

  • The exclusively online LD 500 event is expected to gather more than 300 companies and 20,000 attendees in early September
  • Trxade reported record revenue in Q2 2020 and expects a strong second half of the year
  • If telemedicine services maintain popularity, market analysts project a seven-fold increase for the industry by 2025

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, will present at the virtual LD 500 in early September to an expected online audience of more than 20,000.The event is organized by LD Micro, an independent resource to the microcap world, which started off as a newsletter highlighting unique companies and has transformed into the pre-eminent event platform in the space.

The upcoming LD 500, taking place September 1st-4th, 2020, is the company’s most ambitious project yet, and the first event that can be accessed by anyone. It is expected to feature over 300 companies and more than 20,000 attendees, according to LD Micro President Chris Lahiji.

“For the first time in ten years, we were unable to host our mid-year conference, which caused us to dream up the LD 500,” stated Lahiji. “While the economy and financial world have been turned upside down, investor interest is as high as we have ever seen, and we will have something for everyone.”

This news comes on the heels of Trxade Group reporting record revenues for the second quarter of 2020 and projections for a strong second half of the year. According to a company announcement, revenues increased 244% to a record $6.6 million, compared to revenue of $1.9 million in the same quarter last year. Second quarter revenue was up 199% when compared to revenues of $2.2 million in the first quarter of 2020 (http://nnw.fm/IfYds).

“As we move through the second half of 2020, we are better positioned than ever to execute upon our vision of continued growth of the platform, driven by new independent pharmacies, new suppliers and distributors,” Chairman and Chief Executive Officer Suren Ajjarapu said.

The revenue surge was primarily due to a significant increase in personal protective equipment (“PPE”) sales by the company’s Integra Pharma segment in response to the COVID-19 pandemic.

During the COVID-19 crisis, telehealth services have rapidly expanded. As a result, the company has been working to raise awareness of its supply chain trading platform that includes medical consultation and prescription drug solutions. As the spread of the novel coronavirus unexpectedly reached pandemic proportions and triggered the need for infection-fighting policies, Trxade Group has developed measures to help patients and providers continue to access resources through a virtual environment that is safe from contagion.

If telemedicine services maintain popularity with patients, and insurance providers continue to be responsive to reimbursing telehealth claims, market analysts at McKinsey & Company forecast a $250 billion telehealth market (http://nnw.fm/zYUhR) while Frost & Sullivan projects a seven-fold increase in telehealth by 2025 (http://nnw.fm/eEivE).

Headquartered in Tampa, Florida, Trxade Group, Inc. is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. The company operates across all 50 states with the central mission of making healthcare services affordable and accessible.

Trxade operates via four synergistic platforms: (1) B2B trading platform with 11,725 registered pharmacies; (2) Integra Pharma Solutions, the company’s virtual wholesale division; (3) Bonum Health which offers affordable telehealth services; and (4) the DelivMeds app, a nationwide mail order delivery distribution network for independent pharmacies.

For more information, visit the company’s website at www.TrxadeGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, August 13th, 2020 Uncategorized Comments Off on $MEDS to Present at LD Micro’s LD 500 Virtual Conference

$WTER Delivers Record First Quarter Revenue of $14.2 million

SCOTTSDALE, Ariz., Aug. 13, 2020 — The Alkaline Water Company Inc. (NASDAQ and CSE: WTER) (the “Company”), a producer of bottled alkaline drinking water, flavor-infused waters, and CBD infused products sold under the brand name Alkaline88®, A88-Infused™, and A88CBD™, respectively. Today, the Company announces record revenue of $14.2 million for the fiscal first quarter ended June 30, 2020. The Company also filed with the SEC its Form 10-K for the full fiscal year 2020 and its form 10-Q for the fiscal first quarter of 2021 on August 13, 2020.

Key Highlights:

  • Record fiscal first quarter 2021 revenue increased approximately 40% year over year and 18% sequentially.
  • Earnings per share of ($0.05) improved by 57.3% compared to the prior-year quarter.
  • July’s purchase orders were the second-highest of any month in the Company’s history.

“Fiscal 2021 is off to a solid start with strong momentum across all our lifestyle brands. We delivered record fiscal Q1 revenue of $14.2 million and showed operational discipline with expenses down 5% year-over-year. During the last six months, we have performed exceptionally well, and according to Nielsen data, we outperformed the value-add water category by approximately 12% on a dollar sales basis and 16% on a unit basis. Our operational excellence during the pandemic is creating significant goodwill with existing channel partners, who are showing a stronger commitment to our brands, especially our single-serve, aluminum, and flavored water offerings. Alkaline88 remains one of the top-selling brands in the value-added water category. According to recent trade data, Alkaline88 was one of the two brands that showed double-digit growth as the category briefly turned negative in early July. With a solid sales pipeline in new and existing trades, our robust lineup of innovative products, and growing momentum in our lifestyle brands, we are excited about the opportunities in fiscal 2021 and beyond,” stated Richard A. Wright, president and chief executive officer of The Alkaline Water Company Inc.

“We also see momentum building in our A88CBD brand. Our e-commerce site, A88CBD.com, is exceeding our expectations with strong visitation metrics, sales conversion rates, and repeat customers. Also, our sales pipeline for our A88CBD line of topical and ingestible products is robust. We are finding great success with non-traditional retailers like CBD only dispensaries, MSO’s and high-volume online stores. In recent weeks we have added approximately 25 retail locations and 2 online wholesalers that now carry the A88CBD brand. We expect our line of in-demand topical and ingestible products to accelerate growth in the second half of fiscal 2021 as retailers undergo planogram resets. As a trusted brand with an established national network of brokers, distributors, and trade partners, we believe we can be one of the leading providers of high-quality CBD products to brick-and-mortar stores across the nation.”

Fiscal 2021 First Quarter Financial Results (unaudited)
(All amounts are in U.S. dollars)

  • For the fiscal first-quarter ending June 30, 2020, recorded record revenue of approximately $14.2 million, an increase of 40.1% year-over-year, and 17.6% quarter-over-quarter.
  • Gross profit in the fiscal first quarter was $5.8 million, an increase of 41.8% year over year, primarily due to the increase in revenue.
    o Gross margin improved 50 basis points to 41.1%.
  • Total operating expenses for the fiscal first quarter were $8.6 million, a decrease of 4.5% year over year.
  • Net loss for the fiscal first quarter was $3.0 million or $0.05 per share versus a net loss of $5.1 million or $0.12 per share in the fiscal first quarter of 2019.

Recent Business and Operational Highlights

National Footprint and Channel Expansion

  • Alkaline88® flagship brand of premium alkaline water is now available in 70,000 stores across all trades in the U.S.
  • Delivered 300,000 aluminum bottles of Alkaline88® in 500-ml sustainable single-serve packaging to the California and Texas markets.
  • Expands online and brick and mortar channels for A88CBD™ portfolio of products.
    o Products are now available in approximately 25 retail locations, including Elevated Wellness CBD, CBD Emporium, Alchemist Kitchen, Pure CBD, Vitamin Plus (select locations), and online at AmazonCBD.cohealwithnature.com, and DirectCBDOnline.com.
  • Accelerated convenience store growth strategy with several new distribution agreements.
    o Added the nation’s second-largest distributor, which extends our reach to approximately 15,000 stores nationwide.
    o Potential reach canvases the entire nation, with a concentration in California, Texas, and the Northwest markets.
    o Added over 10,000 new convenience stores since the inception of the program and the Company expects to reach approximately 25,000 convenience stores by the end of fiscal 2021.
  • Expanded into natural and specialty food channel with C.A. Fortune.
  • Expanded national distribution with KeHE for flavor-infused waters and UNFI and broker C.A. Fortune for its A88CBD™ portfolio of products.
  • Received summer commitments from 12,500 retailers for flavor-infused products.

Innovation and Product Portfolio Expansion

  • Launched A88 infused™ and introduced a robust line of A88CBD™ infused portfolio of products.
    o Launched A88CBD™ topical portfolio in January and the A88CBD™ ingestibles product line in May of 2020.
    o The topical product lineup includes salves, balms, lotions, essential oils, and bath-salts, all made with lab-tested full and broad-spectrum hemp.
    o The ingestible product lineup includes gummies, capsules, and tinctures, all made with lab-tested broad-spectrum hemp.
  • Announced new single-serve 500ml Eco-friendly Aluminum bottles.
    o To be carried by national distributor KeHE with support from leading national broker C.A. Fortune.

Corporate Development

  • Enhanced digital customer experience by adding new content and features to A88CBD.com
    o Strong monthly viewership across both e-commerce platforms with an approximately 26% return customer rate on the A88CBD™ product line.
  • Featured and showcased A88 Infused™ flavor-infused and A88CBD™ product line at various national expos and tradeshows.
    o Ranked #1 best selling national brand by units sold at the 2020 KeHE Holidays of Hope Show.
  • Listed on the Canadian Securities Exchange and delisted from the TSX Venture Exchange.
  • Alkaline88® selected premier marketing firm, Davis Elen, as the agency of record.

Brand Awareness

  • Alkaline88® remains the #1 selling bulk alkaline water nationally.
  • Introduced new brand ambassadors, Justin Sander and Brent Marks, two of dirt-track racing rising stars.
  • Alkaline88® showcased the A88CBD™ product portfolio at the ECRM® CBD Health and Beauty Jacksonville Expo.
  • Announces new marketing initiatives and brand refresh for Alkaline88®.

The following table summarizes the operating results for the three months ended June 30, 2020, and 2019 (Unaudited):

(All Amounts are in U.S. dollars)

For the three months ended
June 30, 2020
For the three months ended
June 30, 2019
Year over Year Change %
Revenue $   14,219,424 $   10,153,044 40.1 %
Cost of Good Sold $   8,369,526 $   6,028,197 38.8 %
Gross Profit $   5,849,898 $   4,124,847 41.8 %
Operating Expenses
Sales and Marketing $   4,505,345 $   4,472,460 0.7 %
General and Administrative $   3,947,321 $   4,379,271 -9.9 %
Depreciation $    227,911 $   233,940 -2.6 %
Total Operating Expense $   8,680,577 $   9,085,671 -4.5 %
Total Operating Loss $   (2,830,679 ) $   (4,960,824 ) -42.9 %
Net Loss $   (3,021,003 ) $   (5,056,188 ) -40.3 %
Loss per Share (Basic and Diluted) $   (0.05 ) $   (0.12 ) -57.3 %
Weighted Avg. Shares Outstanding (Basic and Diluted) 57,231,724 40,849,600 40.1 %

Conference Call Information

The Alkaline Water Company Inc. will conduct a conference call to review its operating results for the quarter ended June 30, 2020, on Thursday, August 13, 2020, at 5:00 PM Eastern Time. This call may include material information not included in this press release.

Date: August 13, 2020
Time: 5:00 PM Eastern Time (E.T.)
Dial-in Number for U.S. and Canadian Callers: 877-407-8293
Dial-in Number for International Callers (Outside of the U.S. and Canada): 201-689-8349

Participating on the call will be the Company’s President and CEO Richard A. Wright and Chief Financial Officer David Guarino, who will discuss operational and financial highlights for the fiscal first quarter, as well as its outlook for the full fiscal year 2021.

To join the live conference call, please dial into the above-referenced telephone numbers five to 10 minutes prior to the scheduled call time.

A replay will be available for one week starting on August 14, 2020, at approximately 10:30 AM (E.T.). To access the replay, please dial 877-660-6853 in the U.S. or Canada and 201-612-7415 for international callers. The conference ID# is 13708393.

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company Inc. (NASDAQ and CSE: WTER) is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88®, is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88® delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts our trademarked label ‘Clean Beverage.’ Quickly being recognized as a growing lifestyle brand, Alkaline88® launched A88 infused™ in 2019 to meet consumer demand for flavor-infused products. A88 Infused™ flavored water is available in six unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the Company launched A88CBD™ brand, featuring a broad line of topical and ingestible products. These products are made with lab-tested full and broad-spectrum hemp and include salves, balms, lotions, essential oils, bath-salts, CBD infused drinks, tinctures, capsules, gummies, and powder packs. To purchase A88CBD™ products online, visit us at www.A88CBD.com. To learn more about The Alkaline Water Company Inc., please visit www.thealkalinewaterco.com or connect with us on Facebook, Twitter, Instagram, or LinkedIn.

Notice Regarding Forward-Looking Statements

This news release contains “forward-looking statements.” Statements in this news release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the following: that the Company is excited about the opportunities in fiscal 2021 and beyond; that the Company expects its line of in-demand topical and ingestible products to accelerate growth in the second half of fiscal 2021 as retailers undergo planogram resets; that the Company believes it can be one of the leading providers of high-quality CBD products to brick-and-mortar stores across the nation; and that the Company expects to reach approximately 25,000 convenience stores by the end of fiscal 2021.

The material assumptions supporting these forward-looking statements include, among others, that the demand for the Company’s products will continue to significantly grow; that the past production capacity of the Company’s co-packing facilities can be maintained or increased; that there will be increased production capacity through implementation of new production facilities, new co-packers and new technology; that there will be an increase in number of products available for sale to retailers and consumers; that there will be an expansion in geographical areas by national retailers carrying the Company’s products; that there will be an expansion into new national and regional grocery retailers; that there will be an expansion into new e-commerce, home delivery, convenience, and healthy food channels; that there will not be interruptions on production of the Company’s products; that there will not be a recall of products due to unintended contamination or other adverse events relating to the Company’s products; and that the Company will be able to obtain additional capital to meet the Company’s growing demand and satisfy the capital expenditure requirements needed to increase production and support sales activity. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, governmental regulations being implemented regarding the production and sale of alkaline water or any other products, including products containing hemp/CBD; the fact that consumers may not embrace and purchase any of the Company’s CBD-infused products; the fact that the Company may not be permitted by the FDA or other regulatory authority to market or sell any of its CBD-infused products; additional competitors selling alkaline water and enhanced water products in bulk containers reducing the Company’s sales; the fact that the Company does not own or operate any of its production facilities and that co-packers may not renew current agreements and/or not satisfy increased production quotas; the fact that the Company has a limited number of suppliers of its unique bulk bottles; the potential for supply-chain interruption due to factors beyond the Company’s control; the fact that there may be a recall of products due to unintended contamination; the inherent uncertainties associated with operating as an early stage company; changes in customer demand and the fact that consumers may not embrace enhanced water products as expected or at all; the extent to which the Company is successful in gaining new long-term relationships with new retailers and retaining existing relationships with retailers; the Company’s ability to raise the additional funding that it will need to continue to pursue its business, planned capital expansion and sales activity; and competition in the industry in which the Company operates and market conditions. These forward-looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States and Canada. Although the Company believes that any beliefs, plans, expectations and intentions contained in this news release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Readers should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents the Company files with the SEC, available at www.sec.gov, and on the SEDAR, available at www.sedar.com.

The Alkaline Water Company Inc.

Richard A. Wright
President and CEO

Sajid Daudi
Director of Investor Relations & Corporate Communications
800-923-1910
investors@thealkalinewaterco.com

Media

Jessica Starman
888-461-2233
jessica@elev8newmedia.com

Thursday, August 13th, 2020 Uncategorized Comments Off on $WTER Delivers Record First Quarter Revenue of $14.2 million

$SRAX Sequire Platform Proof Positive of Company’s Relevance in Today’s Changing Markets

  • Sequire now available as free mobile app, gives SRAX clients benefits of entire platform
  • With mobile app, companies can monitor behaviors, contributions of investors anytime and anywhere
  • Since its release, Sequire has surpassed 500,000 active investors and traders, sales have exceeded $2.5 million

In a world transformed by a worldwide epidemic, companies that offer flexible services and options that support new ways of doing business appear to be ideally positioned for success. With Sequire, SRAX Inc. (NASDAQ: SRAX) has honed in on precisely what today’s public businesses are looking for. The proprietary investor intelligence and communications platform provides an intuitive, virtual method for companies to monitor retail and institutional investors as well as activate media campaigns to engage existing investors while attracting new ones — and the newest additions to the platform illustrate how effective SRAX is at adapting to a world that is moving online.

Originally available as a computer app, Sequire is now also available as a mobile app and can be downloaded for free on the App Store and Google Play (http://nnw.fm/WwDow), allowing SRAX clients to enjoy all the benefits of the entire platform regardless of where they are. With Sequire, businesses can unlock stock buyers’ behaviors and trends; manage and monitor return on investment from investor relations programs and corporate communications firms; and engage current and potential stock buyers at their trading desks, investor events or at home on both desktop or mobile.

“We are thrilled to launch the Sequire mobile app enabling our clients to now monitor their investors’ behaviors and their contributions anytime and anywhere,” said SRAX CEO and founder Christopher Miglino. “We’ll also be launching more exciting mobile features in the next few months, so stay tuned.”

Clear evidence of SRAX’s ability to recognize what today’s market demands is the success of the platform. Since its release, Sequire has surpassed 500,000 active investors and traders while sales have exceeded $2.5 million in Q2 2020 (http://nnw.fm/ERanK). In addition, the addition of Sequire’s relatively new Virtual Roadshow, which allows companies to host one-on-one or one-to-many video and audio meetings (http://nnw.fm/ibr0R), shows how nimble and relevant the company can be.

With virtual communication deemed an essential component of today’s business operations, the Virtual Roadshow provides a safe, effective way for companies to present their stories to new shareholders, offer quarterly and annual updates to existing shareholders, and reach out to a wide range of individuals and entities.

“The ecosystem for investor events will be changed forever after the current environment,” said Miglino. “Investors and issuers will no longer need to meet in person. New technologies are providing the tools that issuers need to meet with current and prospective investors. The organizers of these events are the cornerstone of the industry and our system will allow for them to create their own events on the platform and profit from letting issuers invite investors from proprietary lists to the issuers roadshows. Video is the future of investor communication, and we are thrilled to add this feature to the platform.”

SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury, and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. In addition to BIGtoken, the company offers Sequire, a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, August 13th, 2020 Uncategorized Comments Off on $SRAX Sequire Platform Proof Positive of Company’s Relevance in Today’s Changing Markets

$SGLB Announces Appointment of 3D Printing Industry Veteran

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, today announced its appointment of Steve Immel to the position of Senior Director Business Development, North America. Steve, a veteran of the 3D printing industry, will be responsible for engaging with 3D printer OEMS, additive manufacturers, academic institutions and research organizations to propel Sigma Labs PrintRite3D(R) in-process quality assurance solutions into production applications. “We are extremely pleased to welcome someone of Steve Immel’s caliber,” Sigma Labs’ Vice President of Business Development, Ron Fisher, stated in the news release. “Steve brings to Sigma Labs a unique mix of in-depth experience in CAD/CAM/CAE software, 3D printer hardware and production manufacturing combined with passion for advancing the industry. He will be a great asset to our company and, most important, to our customers and partners.”

To view the full press release, visit http://nnw.fm/qX2Dg

About Sigma Labs, Inc.

Sigma Labs is a leading provider of quality assurance software to the commercial 3D metal printing industry under the PrintRite3D(R) brand. Sigma specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D(R) for 3D metal advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process and informs the production manager of quality issues. Sigma Labs’ software product is a major catalyst for the acceleration and adoption of 3D metal printing. For more information, please visit www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, August 13th, 2020 Uncategorized Comments Off on $SGLB Announces Appointment of 3D Printing Industry Veteran

$POAI Reports Second Quarter 2020 Financial Results, Provides Business Update

Increases Readiness for Commercialization with Expanded Portfolio of Solutions for Precision Medicine

NEW YORK, Aug. 13, 2020 — Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today reported financial results for the quarter ended June 30, 2020 and provided a business update.

Financial and Business Highlights of Q2 and Recent Developments

  • Secured first commercial sale of its novel ovarian cancer cell media for cancer cells collected from patient derived samples through its TumorGenesis division
  • Completed the acquisition of Quantitative Medicine (“QM”), a biomedical analytics and computational biology company (July 2020), in an all-stock transaction valued at approximately $1.8 million
  • Completed an asset purchase agreement to acquire Soluble Therapeutics and its HSC™ Technology along with BioDtech Inc.
  • Refreshed Board of Directors with appointment of three new independent directors
  • Strengthened balance sheet with recent equity offerings.
  • Management anticipates a need to raise additional capital to support operations and near-term debt repayments

“During the second quarter we reached a major milestone in our journey towards full commercialization with the first sale of our novel ovarian cancer cell media to a top-rated medical university in New England,” commented Dr. Carl Schwartz, Predictive Oncology CEO. “This sale serves as a solid proof point of our mission and is a significant achievement towards improving healthcare outcomes for cancer patients. Our unique media significantly expands the number of ovarian cancer cell types that can be studied representing nearly 95% of all ovarian cancers, many of which have never been cultured before now, and reduces waste in cancer research.”

“Our acquisitions of Soluble Therapeutics and BioDtech position us with next level capabilities that we believe will materially advance our progress towards developing new targeted therapies in collaborations with pharmaceutical companies and enable meaningful expansion of revenue opportunities,” added Dr. Schwartz. “Soluble Therapeutics assets will help us to provide the best formulation with the highest concentration and the most stable solution for protein and peptide-based drugs while the acquisition of BioDtech gives us governance over its testing solution for unmasking endotoxins. Together, we believe these acquisitions will substantially advance the discipline of precision medicine and accelerate our pursuit of monetizing our full portfolio of assets.”

Dr. Schwartz continued, “We also completed our acquisition of QM in early 2020, bringing its proven, machine learning platform, CoRE, into our portfolio of assets in our Helomics business and equipping us with a framework for an end-to-end solution for precision medicine. We are encouraged by the emerging opportunities this opens for us to further revolutionize AI-driven predictive modeling that can be used to accelerate the development of personalized patient treatments.”

“Our Helomics business continues to make solid progress with our CancerQuest 2020 initiative and our collaboration with UPMC Magee Hospital to build AI-driven predictive models for the treatment of ovarian cancer,” added Dr. Schwartz. “Thus far, we have received outcome data, completed the second phase of sequencing and have begun the process to build our AI-model. We are on track to complete the study and have our first AI-driven model in accordance with our workplans, despite a later start date that was triggered by a delay in funding resulting from the COVID-19 pandemic. We expect to have our first AI-driven model completed in the second half of 2020. Just as important, we have been ramping up our commercial outreach activities with large pharma companies to build a pipeline of targeted opportunities ahead of model completion.”

Dr. Schwartz concluded, “We further bolstered our liquidity position with approximately $4.6 million in gross proceeds from a registered direct offering of common stock, the exercise of warrants and the issuance of additional warrants. Although we still have significant short-term debt obligations, the equity offerings demonstrate investor confidence, extend our cash runway and provide working capital to continue our pursuit of developing commercially viable solutions for large pharma. From a governance perspective, we refreshed our board operations with the appointment of three new independent directors, who collectively have extensive industry, financial and business development experience and a rich network of industry contacts that we believe will be extremely advantageous as we execute the next steps in our business plan.”

Second Quarter 2020 Financial Results

Revenues were $183,000 compared with $286,000 for the second quarter of 2019. Revenues in both years were primarily driven through the sale of Predictive Oncology’s proprietary STREAMWAY units, of which 1 unit and 7 units were sold in the three months ended June 30, 2020 and 2019, respectively.

Gross margin was 53% in the second quarter of 2020 compared with 59% in the 2019 period. The decrease was due to higher costs on lower revenue in the current period compared to the prior year period. General & administrative expenses decreased 3% to $3.2 million in the second quarter of 2020 as a result of lower costs related to share-based compensation. Operations expenses decreased to $521,000, compared with $1.3 million in the second quarter of 2019.

Net loss was $3.6 million, inclusive of other income of $1.3 million related to the revaluation of equity method investments and gains on elimination of notes outstanding, and interest and dividend income, compared with net income of $1.5 million for the second quarter of 2019. The second quarter of 2020 includes a gain on the revaluation of cash advances to Helomics of $1.2 million and a gain of $6.2 million on a revaluation of equity method investment.

Outlook

Management continues to focus its resources on the Helomics and TumorGenesis divisions and the Company’s primary mission of applying artificial intelligence to precision medicine, drug discovery and the mediums used to replace rats and mice in preliminary cancer studies. Management reaffirms that it is focusing the majority of its resources on maximizing opportunities within the Company’s precision medicine business.

About Predictive Oncology Inc.

Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™, patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

Forward-Looking Statements

Portions of the narrative set for this document that are not statements of historical or current facts are forward-looking statements, in particular, the commercial outlook provided above. Our actual future performance may materially differ from that contemplated by the forward-looking statements as a result of a variety of factors.

These factors include, in addition to those mentioned elsewhere herein:

  • We may not be able to continue operating without additional financing;
  • Current negative operating cash flows;
  • The terms of any further financing, which may be highly dilutive and may include onerous terms;
  • Risks related to the 2019 merger with Helomics including; 1) significant goodwill could result in further impairment; 2) possible failure to realize anticipated benefits of the merger; 3) costs associated with the merger may be higher than expected; 4) the merger may result in the disruption of our existing businesses; and 5) distraction of management and diversion of resources;
  • Risks related to our partnerships with other companies, including the need to negotiate the definitive agreements; possible failure to realize anticipated benefits of these partnerships; and costs of providing funding to our partner companies, which may never be repaid or provide anticipated returns;
  • Risks related to the transaction with Quantitative Medicine including: 1) possible failure to realize anticipated benefits of the transaction; 2) costs associated with the acquisition may be higher than expected; 3) the transaction may result in the disruption of our existing businesses; and 4) distraction of management and diversion of resources;
  • Risk that we will be unable to protect our intellectual property or claims that we are infringing on others’ intellectual property;
  • The impact of competition;
  • Acquisition and maintenance of any necessary regulatory clearances applicable to applications of our technology;
  • Inability to attract or retain qualified senior management personnel, including sales and marketing personnel;
  • Risk that we never become profitable if our product is not accepted by potential customers;
  • Possible impact of government regulation and scrutiny;
  • Unexpected costs and operating deficits, and lower than expected sales and revenues, if any;
  • Adverse results of any legal proceedings;
  • The volatility of our operating results and financial condition;
  • Management of growth;
  • Material and adverse effects of the COVD-19 pandemic, including impact on a significant supplier; a reduction in on-site staff at several of our facilities, resulting in delayed production and less efficiency; impact on sales efforts; impact on accounts receivable and terms demanded by suppliers; and possible impact on financing transactions; and,
  • Other specific risks that may be detailed from time to time in the Company’s reports filed with the SEC, which are available for review at www.sec.gov.

Investor Relations Contact:

Hayden IR
James Carbonara
(646)-755-7412
james@haydenir.com

— Tables Follow –

PREDICTIVE ONCOLOGY INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

June 30, 2020   December 31, 2019
(unaudited) (audited)
ASSETS
Current Assets:
Cash and Cash Equivalents $ 3,394,078 $ 150,831
Accounts Receivable 272,493 297,055
Inventories 235,368 190,156
Prepaid Expense and Other Assets 426,704 160,222
Total Current Assets 4,328,643 798,264
Fixed Assets, net 2,409,721 1,507,799
Intangibles, net 3,539,597 3,649,412
Lease Right-of-Use Assets 1,528,150 729,745
Goodwill 15,690,290 15,690,290
Total Assets $ 27,496,401 22,375,510
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts Payable $ 2,449,046 $ 3,155,641
Notes Payable – Net of Discounts of $282,099 and $350,426 4,412,377 4,795,800
Accrued Expenses 2,649,160 2,371,633
Derivative Liability 4,629,570 50,989
Deferred Revenue 38,582 40,384
Lease Liability 473,043 459,481
Total Current Liabilities 14,651,778 10,873,928
Lease Liability – Net of current portion 1,055,107 270,264
Other long-term liabilities 98,358
Total Liabilities 15,805,243 11,144,192
Stockholders’ Equity:
Preferred Stock, 20,000,000 authorized inclusive of designated below
Series B Convertible Preferred Stock, $.01 par value, 2,300,000 shares authorized, 79,246 and 79,246 shares outstanding 792 792
Series D Convertible Preferred Stock, $.01 par value, 3,500,000 shares authorized, 0 and 3,500,000 outstanding 35,000
Series E Convertible Preferred Stock, $.01 par value, 350 shares authorized, 0 and 258 outstanding 3
Common Stock, $.01 par value, 100,000,000 shares authorized, 13,190,787 and 4,056,652 outstanding 131,908 40,567
Additional paid-in capital 102,163,864 93,653,667
Accumulated Deficit (90,605,406 ) (82,498,711 )
Total Stockholders’ Equity 11,691,158 11,231,318
Total Liabilities and Stockholders’ Equity $ 27,496,401 $    22,375,510

PREDICTIVE ONCOLOGY INC.
CONDENSED CONSOLIDATED STATEMENTS OF NET LOSS
(Unaudited)

                                                                                                                   
                                                                                                                                                                      

Three Months Ended      Six Months Ended
June 30,   
June 30, 
  2020   2019   2020   2019
Revenue $ 182,784 $ 286,151 $ 477,727 $ 541,392
Cost of goods sold 85,261 118,390 177,918 192,106
Gross margin 97,523 167,761 299,809 349,286
General and administrative expense 3,211,817 3,310,368 6,040,293 4,808,314
Operations expense 521,116 1,271,258 1,069,869 1,737,824
Sales and marketing expense 133,015 685,029 397,424 1,239,245
Total operating loss (3,768,425 ) (5,098,894 ) (7,207,777 ) (7,436,097 )
Gain on revaluation of cash advances to Helomics          – 1,222,244                             –                1,222,244
Other income 52,965 (3,223 ) 52,968 50,209
Other expense (729,837 ) (607,343 ) (1,846,912 ) (1,157,711 )
Gain (loss) on derivative instruments (422,081 ) (211,940 ) (394,974 ) (231,348 )
Gain on notes receivables associated with asset purchase                1,290,000                              –                1,290,000                              –
Loss on equity method investment 439,637
Gain on revaluation of equity method in investment                                – 6,164,260                               –                6,164,260
Net income (loss) $ (3,577,378 ) $ 1,465,104 $ (8,106,695 ) $ (1,828,080 )
Deemed dividend on Series E Convertible Preferred Stock                                –    20,398                                –                     20,398
Net income (loss) attributable to common shareholders per common shares-basic and diluted $ (3,577,378 ) $             1,444,706 $         (8,106,695 ) $           (1,848,478 )
Gain (loss) per common share basic $   (0.36 ) $   0.49 $   (1.10 ) $  (0.81 )
Gain (loss) per common share diluted   (0.36 )   0.24   (1.10 )   (0.81 )
Weighted average shared used in computation – basic 9,838,152     2,960,937                            7,362,240             2,274,754
Weighted average shared used in computation – diluted 9,838,152  6,007,078 7,362,240 2,274,754
Thursday, August 13th, 2020 Uncategorized Comments Off on $POAI Reports Second Quarter 2020 Financial Results, Provides Business Update

$POAI Connecting Medicine and Engineering Could Hold the Key to Better Healthcare

Engineering and medicine have been synchronized in various ways. For instance, prosthetic hips, bedside monitors, artificial valves and MRI machines emerged due to the interface of medicine and engineering. Since medical and health records involve the storage of big data, artificial intelligence and personalized medicine can attest to the importance of engineering in medicine.

Rise of Biomedical Engineering

Engineering faculties have been preparing for the future of biomedical engineering. They have to induct their students to learn the concepts and tools of engineering and how to apply them in the biomedical field. For example, designing implants capable of surviving for years in the body is speeding the need for biomedical engineers.

Several institutions have also accredited biomedical engineering programs to try and meet the market demand. Due to the changing trends in engineering-based education, students are equipped to collaborate with the challenges by subjecting them to group-based projects. Through these projects, the upcoming medical engineers have the expertise on some medical terms hence making them communicate effectively with physicians.

Shortage in Medical Training

The curriculum in most medical schools does not help physicians to develop some of the required skills. Every physician is using advanced technology in their daily work, but only a few of them have the technical education necessary to develop it. Most institutions have now started new programs that involve the blending of medical and engineering education.

However, most of these efforts employ an outdated physician-centered method that aims to train one person in two subjects. They need to be prepared to collaborate in multidisciplinary teams. The two-discipline one-person approach has a rich history in medical institutions, especially in M.D and the Ph.D studies. These programs have been successful in some disciplines, and only a few doctors are trained in them.

Collaboration Between Medicine and Engineering is Inevitable

A proven and scalable approach to link medicine and engineering is the only way that will teach healthcare workers and engineers to work together as a team. For example, some institutions promote innovation by fixing engineering into nursing and clinical surroundings and medical students into engineering laboratories.

After students have been embedded, they acquire cultural literacy, technical vocabulary, and experience working with multidisciplinary teams. It, in turn, provides them with a good base for careers in innovation and health sectors. Fortunately, educating physicians and engineers to cooperate is getting faster and cheaper. Additionally, it is more practical than specialty building programs to train healthcare workers-engineers or propelling more biomedical engineering courses.

The approach has built successful and experienced programs such as Coulter Translational Partners Program and Stanford Biodesign. It is gaining more popularity in institutions where medical and engineering students are on the same campus.

Bridging the Gap

Finding solutions on how to reduce the disciplinary and literal separation between medicine and engineering is important. It will help expand and cultivate innovation at the interface. The new specialized training programs may also play a role in engineering-medical cooperation. However, promoting collaboration within the workforce has the biggest potential in creating a visible impact.

The gainers in the next brand of healthcare innovation will be institutions and firms that will find paths to train nurses, doctors, and engineers to work together. If these three groups can effectively work together to solve the tough healthcare problems, then their institutions will be the bigger players in the field. Analysts say the important convergence between medicine and engineering is well-known to companies like Predictive Oncology (NASDAQ: POAI) who walk the thin line between those disciplines.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, August 13th, 2020 Uncategorized Comments Off on $POAI Connecting Medicine and Engineering Could Hold the Key to Better Healthcare

$NETE Reports Second Quarter 2020 Financial Results

MIAMI, Aug. 13, 2020 — via NetworkWire — Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multichannel environment including point-of-sale (“POS”), e-commerce and mobile devices, today reports its financial results for the second quarter ended June 30, 2020.

Second Quarter 2020 Financial Results

  • Total transaction volume decreased to $717.9 million, as compared to $950.2 million for the same comparable period.
  • Net revenue decreased to $13.7 million, as compared to $16.5 million for the same comparable period in 2019.
  • North American Transactions Solutions revenue decreased to $13.0 million, as compared to $15.7 million for the same comparable period.
  • International Transaction Solutions revenue decreased slightly to $0.74 million, as compared to $0.75 million in 2019.
  • Operating expenses decreased to $2.2 million, as compared to $5.2 million for the same comparable period.
  • Gross margin decreased to $2.2 million, as compared to $2.6 million for the same comparable period.

“The COVID-19 pandemic continued to negatively impact our financial results during the second quarter of this year. Our ability to adapt quickly by implementing safety protocols to protect our employees has been successful so far, and we are happy to report we have had zero cases of COVID-19 among our employees. We also implemented cost-cutting initiatives while boosting support for our merchants through e-commerce solutions, contactless payment alternatives and online food ordering for restaurants,” commented Oleg Firer, CEO of Net Element. “We continue working diligently to increase shareholder value as we continue to work toward the proposed merger with Mullen Technologies Inc.”

Results of Operations for the Three Months Ended June 30, 2020, Compared to the Three Months Ended June 30, 2019

We reported a net loss attributable to common stockholders of approximately $300,000 or $0.08 per share loss for the three months ended June 30, 2020, as compared to a net loss of approximately $1.5 million or $0.37 per share loss for the three months ended June 30, 2019. The decrease in net loss attributable to stockholders of approximately $1.2 million was primarily due to the reorganization of the labor force, including layoffs, which reduced our selling, general and administrative expenses.

The following table sets forth our sources of revenues, cost of revenues and the respective gross margins for the three months ended June 30, 2020, and 2019.

Three
Months Ended
Three
Months Ended
Increase /
Source of Revenues June 30, 2020 Mix June 30, 2019 Mix (Decrease)
North American Transaction Solutions $   12,977,536 94.6% $   15,737,998 95.5% $ (2,760,462 )
International Transaction Solutions 741,073 5.4% 749,313 4.5% (8,240 )
Total $   13,718,609 100.0% $   16,487,311 100.0% $ (2,768,702 )
Six
Months Ended
% of Six
Months Ended
% of Increase /
Cost of Revenues June 30, 2020 revenues June 30, 2019 revenues (Decrease)
North American Transaction Solutions $   23,840,300 84.7% $   25,212,812 83.8% $ (1,372,512 )
International Transaction Solutions 996,895 70.0% 948,700 66.2% 48,195
Total $   24,837,195 84. $   26,161,512 83.0% $ (1,324,317 )
Three
Months Ended
% of Three
Months Ended
% of Increase /
Gross Margin June 30, 2020 revenues June 30, 2019 revenues (Decrease)
North American Transaction Solutions $   1,961,508 15.1% $   2,293,924 14.6% $ (332,416 )
International Transaction Solutions 220,314 29.7% 292,022 39.0% (71,708 )
Total $   2,181,822 15.9% $   2,585,946 15.7% $ (404,124 )

Net revenues consist primarily of service fees from transaction processing. Net revenues were approximately $13.7 million for the three months ended June 30, 2020, as compared to $16.5 million for the three months ended June 30, 2019. The decrease in net revenues in our North American Transaction Solutions segment was primarily driven by the adverse impact of the COVID-19 pandemic on our end-to-end payment volumes and gateway transactions.

Cost of revenues represents direct costs of generating revenues, including commissions, mobile operator fees, interchange expense, processing, and non-processing fees. Cost of revenues for the three months ended June 30, 2020, were approximately $11.5 million as compared to approximately $13.9 million for the three months ended June 30, 2019. This decrease is in line with the decrease in revenues for the three months ending June 30, 2020.

The gross margin for the three months ended June 30, 2020, was approximately $2.2 million, or 15.9%, as compared to approximately $2.6 million, or 15.7%, for the three months ended June 30, 2019. The gross margin percentage was in line with the results from the previous comparable period.

Operating Expenses Analysis:

Operating expenses were approximately $2.2 million for the three months ended June 30, 2020, as compared to $5.2 million for three months ended June 30, 2019. Operating expenses for the three months ended June 30, 2020, primarily consisted of selling, general and administrative expenses of approximately $1.4 million and depreciation and amortization of approximately $0.8 million. Operating expenses for the three months ended June 30, 2019, primarily consisted of selling, general and administrative expenses of approximately $2.3 million; non-cash compensation of $2.0 million; and depreciation and amortization expense of approximately $0.7 million.

The components of our selling, general and administrative expenses are reflected in the table below.

Selling, general and administrative expenses for the three months ended June 30, 2020, and 2019 consisted of operating expenses not otherwise delineated in our Condensed Consolidated Statements of Operations and Comprehensive Loss, as follows:

Three months ended June 30, 2020
Category North American
Transaction
Solutions
International
Transaction
Solutions
Corporate
Expenses &
Eliminations
Total
Salaries, benefits, taxes and contractor payments $   536,915 $   91,825 $   118,574 $   747,314
Professional fees 55,336 39,537 241,288 336,161
Rent 13,070 13,325 39,093 65,488
Business development 32,228 3,805 36,033
Travel expense 638 9,373 39,894 49,905
Filing fees 15,525 15,525
Transaction gains (80,512 ) (80,512 )
Office expenses 41,976 3,759 16,879 62,614
Communications expenses 40,083 46,374 15,863 102,320
Insurance expense 42,000 42,000
Other expenses 292 2,104 6,085 8,481
Total $   720,538 $   125,785 $   539,006 $   1,385,329
Three months ended June 30, 2019
Category North American
Transaction
Solutions
International
Transaction
Solutions
Corporate
Expenses &
Eliminations
Total
Salaries, benefits, taxes and contractor payments $   318,487 $   95,231 $   799,417 $   1,213,135
Professional fees 133,316 72,497 345,723 551,536
Rent 15,277 51,277 66,554
Business development 56,184 489 4,944 61,617
Travel expense 35,511 5,084 33,299 73,894
Filing fees 1,078 17,704 18,782
Transaction losses (12,974 ) (12,974 )
Office expenses 83,122 4,147 12,990 100,259
Communications expenses 41,746 65,717 18,447 125,910
Insurance expense 36,267 36,267
Other (income) expenses 286 2,745 61,059 64,090
Total $   669,730 $   248,213 $   1,381,127 $   2,299,070
Variance
Category North American
Transaction
Solutions
International
Transaction
Solutions
Corporate
Expenses &
Eliminations
Total
Salaries, benefits, taxes and contractor payments $   218,428 $   (3,406 ) $   (680,843 ) $   (465,821 )
Professional fees (77,980 ) (32,960 ) (104,435 ) (215,375 )
Rent 13,070 (1,952 ) (12,184 ) (1,066 )
Business development (23,956 ) (489 ) (1,139 ) (25,584 )
Travel expense (34,873 ) 4,289 6,595 (23,989 )
Filing fees (1,078 ) (2,179 ) (3,257 )
Transaction gains (67,538 ) (67,538 )
Office expenses (41,146 ) (388 ) 3,889 (37,645 )
Communications expenses (1,663 ) (19,343 ) (2,584 ) (23,590 )
Insurance expense 5,733 5,733
Other (income) expenses 6 (641 ) (54,974 ) (55,609 )
Total $   50,808 $   (122,428 ) $   (842,121 ) $   (913,741 )

Salaries, benefits, taxes, contractor payments and professional fees decreased by approximately $0.7 million on a consolidated basis for the three months ended June 30, 2020, as compared to the three months ended June 30, 2019. This was due to the staffing reductions necessary due to the effects of the COVID-19 pandemic on our operations.

Reconciliation of Non-GAAP Financial Measures and Regulation G Disclosure

To supplement its consolidated financial statements presented in accordance with United States generally accepted accounting principles (“GAAP”), the Company provides additional measures of its operating results by disclosing its adjusted net loss attributable to Net Element, Inc. stockholders. Adjusted net loss attributable to Net Element stockholders is calculated as net loss attributable to Net Element stockholders excluding non-cash share-based compensation. The Company discloses this amount on an aggregate and per-share basis. These measures meet the definition of non-GAAP financial measures. The Company believes that application of these non- GAAP financial measures is appropriate to enhance the understanding of the Company’s investors of its historical performance through the use of a metric that seeks to normalize period-to-period earnings. A reconciliation of these non-GAAP financial measures with the comparable financial measures calculated in accordance with GAAP for the quarter ended June 30, 2020, and June 30, 2019, is presented in the following tables.

GAAP Share-based
Compensation
Adjusted Non-GAAP
Three Months Ended June 30, 2020
Net loss attributable to Net Element, Inc. stockholders $   (324,690 ) $   7,500 $   (317,190 )
Basic and diluted earnings per share $   (0.08 ) $   – $   (0.08 )
Basic and diluted shares used in computing earnings per share 4,175,148 4,175,148
Three Months Ended June 30, 2019
Net loss attributable to Net Element, Inc. stockholders $   (1,537,447 ) $   2,005,840 $   468,393
Basic and diluted earnings per share $   (0.37 ) $   0.48 $   0.11
Basic and diluted shares used in computing earnings per share 4,199,076 4,199,076
GAAP
Share-based
Compensation
Adjusted Non-GAAP
Six Months Ended June 30, 2020
Net loss attributable to Net Element, Inc. stockholders $   (1,691,488 ) $   45,900 $   (1,645,588 )
Basic and diluted earnings per share $   (0.41 ) $   0.01 $   (0.40 )
Basic and diluted shares used in computing earnings per share 4,146,396 4,146,396
Six Months Ended June 30, 2019
Net loss attributable to Net Element, Inc. stockholders $   (2,658,292 ) $   2,020,847 $   (637,445 )
Basic and diluted earnings per share $   (0.68 ) $   0.52 $   (0.16 )
Basic and diluted shares used in computing earnings per share 3,908,872 3,908,872
Use of Non-GAAP Financial Measures

Non-GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP measures exclude significant expenses that are required by GAAP to be recorded in the Company’s financial statements and are subject to inherent limitations.

About Net Element

Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprises (“SMEs”) in the U.S. and selected emerging markets. In the U.S., it aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, the Company’s cloud-based restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omnichannel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest-growing companies in North America on Deloitte’s 2017 Technology Fast 500™. In 2017, the Company was recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies.  Further information is available at www.NetElement.com.

Forward-Looking Statements

Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Net Element and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, whether the proposed merger with Mullen Technologies Inc. will materialize and, if so, whether that will result in increased shareholder value; whether the Company will be successful in executing cost savings and other alternative strategies and whether these measures will benefit the Company; what the ultimate impact of the COVID-19 pandemic will have on the Company and its operations; whether the Company will achieve further growth or achieve its goals; and when the Company will reach profitability. Additional examples of such risks and uncertainties include, but are not limited to, (i) Net Element’s ability (or inability) to obtain additional financing in sufficient amounts or on acceptable terms when needed; (ii) Net Element’s ability to maintain existing, and secure additional, contracts with users of its payment processing services; (iii) Net Element’s ability to successfully expand in existing markets and enter new markets; (iv) Net Element’s ability to successfully manage and integrate any acquisitions of businesses, solutions or technologies; (v) unanticipated operating costs, transaction costs and actual or contingent liabilities; (vi) the ability to attract and retain qualified employees and key personnel; (vii) adverse effects of increased competition on Net Element’s business; (viii) changes in government licensing and regulation that may adversely affect Net Element’s business; (ix) the risk that changes in consumer behavior could adversely affect Net Element’s business; (x) Net Element’s ability to protect its intellectual property; (xi) local, industry and general business and economic conditions; and (xii) adverse effects of potentially deteriorating U.S.-Russia relations, including, without limitation, over a conflict related to Ukraine, including a risk of further U.S. government sanctions or other legal restrictions on U.S. businesses doing business in Russia. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K filed by Net Element with the Securities and Exchange Commission. Net Element anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Net Element assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing our plans and expectations as of any subsequent date.

Contact:

Net Element, Inc.
Tel. +1 (786) 923-0502
Media@NetElement.com
www.netelement.com

Corporate Communications:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

Thursday, August 13th, 2020 Uncategorized Comments Off on $NETE Reports Second Quarter 2020 Financial Results

$NETE Electric Vehicle Market Offers Compelling Opportunity for Savvy, Forward-Thinking Companies

New York, Aug. 13, 2020 — NetworkNewsWire (“NNW”) announces the availability of a broadcast titled, “Investors Pile into the Accelerating Electric Vehicle Market.”

To hear the AudioPressRelease please visit: The NetworkNewsAudio News Podcast

To read the full editorial, visit: http://nnw.fm/GQjq7

Net Element Inc.’s (NASDAQ: NETE) legacy business model has been firmly centered within the fintech space, with the company operating a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Net Element has plans to divest itself of its payments processing business and portfolio to transform the company into a pure-play electric vehicles manufacturer going forward.

“We feel, after considering an array of strategic alternatives, that the agreement with Mullen provides our shareholders with the most compelling opportunity,” said Net Element chairman and Chief Executive Officer Oleg Firer. “We conducted an extensive search of companies that have disruptive technologies and believe that Mullen represents the best path forward. COVID-19 has created a unique set of challenges for our payment processing business, as many of our payment processing customers are located in the Northeast, which has been hit especially hard by the coronavirus. We expect that the merger with Mullen will create a new path forward that should reward our long-time shareholders.”

About Mullen Technologies:
Mullen Technologies is a Southern California-based licensed electric vehicle manufacturer with international distribution that operates in various verticals of businesses focusing in the automotive industry: Mullen Automotive, Mullen Energy, Mullen Auto Sales, Mullen Funding Corp., and CarHub. Each of these divisions provide Mullen with diversity of different products and services within the automotive industry.

For more information, please visit: www.MullenUSA.com

About Net Element, Inc. ( NETE)
Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S., the Company aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, its cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500™.  In 2017, Net Element was recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies.

For more information, please visit:  www.NetElement.com

About NetworkNewsAudio

NetworkNewsAudio (“NNA”) allows you to sit back and listen to market updates, CEO interviews and a company AudioPressRelease (“APR”). These audio clips provide snapshots of position, opportunity and momentum. NNA can assist your company by cutting through the overload of information in today’s market. NNA brings its Client Partners unparalleled visibility, recognition and brand awareness. NNA is just one site within our sizable family of 40+ brands within the InvestorBrandNetwork (“IBN”). IBN is a comprehensive provider of news and original articles; we aggregate and syndicate this content for much bigger impact. IBN also adds Press Release Enhancement and a full array of social media communication solutions and has amassed a collective audience that includes millions of social media followers. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, IBN has the unparalleled ability to reach a wide audience comprising investors, consumers, journalists and the general public with an ever-growing distribution network of 5,000+ key syndication outlets across the nation.

For more information, please visit www.NetworkNewsAudio.com or The NetworkNewsAudio News Podcast.

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

NetworkNewsWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, August 13th, 2020 Uncategorized Comments Off on $NETE Electric Vehicle Market Offers Compelling Opportunity for Savvy, Forward-Thinking Companies

$NETE Your Questions About Charging an EV at Home, Answered

If you have ever thought about going green and switching to an electric car, you must have considered exactly how you would charge and recharge it. Unlike the nascent EV industry, combustion engine vehicles have been around for decades and the infrastructure needed to keep them running is basically sewn into the fabric of civilization. But, if you’re buying a sweet new electric car, there are fewer resources at hand, and you probably have a ton of questions about how you’ll charge it, especially at home.

You may also be wondering how long it takes to fully charge an electric vehicle. Behyad Jafari, CEO of Electric Vehicle Council, explains that there are three main varieties of charging portals EV owners can use to charge their cars. First are ordinary wall sockets which take about 18-24 hours, wall boxes which take four hours and fast chargers which take around 40 minutes to fully charge an empty battery. Fast chargers are usually installed in pubic charging stations either in public car parks or on the street.

According to Jafari, if you’re looking to install your own personal charger at home, a wall box is far more suitable than a fast charger. “Fast chargers are very expensive and with the amount of power they need you’d be putting it at a public site,” he says. Jafari adds that when installing a wall box in your own house, “usually the company you bought the car from will have an arrangement in place, some cars come with it and for some, it’s an optional extra.” The automaker may also partner with a supplier who will be dispatched to install wall boxes in the homes of new car owners.

For those living in rental properties, installing a permanent wall box may be impossible. However, you may still have other options at your disposal, Jafari says. “We’re seeing investment in things like providers temporarily installing chargers in rental properties and then taking them away again when they move. We’ve also seen chargers attached to street light poles with two or three spots for electric vehicle charging, and its community knowledge that you don’t park in those unless you need to charge an EV.”

If you cannot or don’t want to install a wall box in your home, “the other option is the undesirable approach some people take which is to hang an extension cord out of the house and into your car,” he says. “A lot of cars come with a plug that has one end to go into the car and the other will look like a regular power plug. It usually comes with the car but there are several websites where you can buy different adapters too.”

Analysts say forward-looking companies like Net Element (NASDAQ: NETE) would willingly work with companies trying to make EV charging facilities more affordable for car buyers.

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Thursday, August 13th, 2020 Uncategorized Comments Off on $NETE Your Questions About Charging an EV at Home, Answered

$ICLK Launches iActivate Upgrade

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced its launch of an upgrade of its ultimate advertising campaign management tool, iActivate. A comprehensive solution, iActivate consolidates a number of ad platforms into one single interface for efficient campaign monitoring and management. “iActivate provides straightforward and intelligent market insights that address the pain points faced by marketers of receiving insufficient and overly-general campaign data from existing ad platforms,” Frankie Ho, president of International Business at iClick, stated in the news release. “iActivate helps brands analyze and understand campaign performance in order to target audiences more accurately, empowering them to respond promptly to market changes. Following the upgrade of iAudience and iActivate, we will continue to leverage iClick’s over 930 million consumer profiles and advanced technology in machine learning and artificial intelligence to enhance and improve our product offerings to provide better solutions to our clients.”

To view the full press release, visit http://nnw.fm/C5UTo

About iClick Interactive Asia Group Limited

iClick Interactive Asia Group is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, iClick’s proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in ten locations worldwide, including Asia and Europe.

For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://nnw.fm/ICLK

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, August 13th, 2020 Uncategorized Comments Off on $ICLK Launches iActivate Upgrade

$UUUU Eyes Opportunity Amid Climate Crisis

Energy Fuels (NYSE American: UUUU) (TSX: EFR) is positioned to capitalize on the government’s recent push for nuclear energy. On June 30, the U.S. House Select Committee released an action plan titled “Solving the Climate Crisis: The Congressional Action Plan for a Clean Energy Economy and a Healthy, Resilient, and Just America.” Among ambitious initiatives, the plan proposes establishment of a national clean-energy standard that encourages zero-emission carbon technologies — such as nuclear — to achieve net-zero emissions in the electricity sector by 2040. A recent article discussing the company’s opportunity amid sweeping reform reads, “As the country’s leading uranium and vanadium producer, Energy Fuels is well positioned to capitalize on the growing demand for clean energy. Energy Fuels has also recycled over 6 million pounds of uranium from its alternate feed recycling program. The carbon-free electricity produced from this recycled uranium would be the equivalent of a train full of coal that stretched from Los Angeles to New York — and back again — thereby avoiding 85 million tons of CO2 emissions. Among clean-energy options, nuclear is recognized as one of the most reliable, affordable and stable, contributing to 55% of all clean-energy production throughout the country in 2019 (http://ibn.fm/JUuM2). In terms of carbon emissions and air pollution reduction, Energy Fuels is one of the greenest companies operating in the U.S.”

To view the full article, visit http://ibn.fm/7JvOz

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant. Its corporate offices are near Denver, Colorado, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the United States today, has a licensed capacity of over 8 million pounds of U3O8 per year and has the ability to produce vanadium when market conditions warrant. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also currently on standby. In addition to the above production facilities, Energy Fuels has one of the largest NI 43-101 compliant uranium resource portfolios in the United States, including several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol UUUU; the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol EFR. For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Thursday, August 13th, 2020 Uncategorized Comments Off on $UUUU Eyes Opportunity Amid Climate Crisis

$DRIO Announces Poster Presentation at the Virtual Association of Diabetes Care and Education Specialists 2020 Annual Conference

DarioHealth Announces Poster Presentation at the Virtual Association of Diabetes Care and Education Specialists 2020 Annual Conference

Observational study results demonstrate improved blood pressure and glycemic control for patients suffering from hypertensive blood pressure and diabetes who used the Dario platform

NEW YORKAug. 13, 2020 — DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, which is being held today, August 13, through August 16, 2020.

Dario Health (PRNewsfoto/DarioHealth Corp.)

The poster, entitled, “Impact of Digital Management on Clinical Outcome in Patients with Chronic Conditions: Diabetes and Hypertension,” details results from an observational study of 345 participants with hypertensive blood pressure at baseline who utilized the Dario digital therapeutics platform.

Results:

Blood pressure

  • All study subjects started with hypertension stage 1, stage 2 or hypertensive crisis levels.
  • They were monitored using the Dario blood pressure monitoring system for three months.
  • 70% of users (243/345) improved their blood pressure reading by 8.4 mmHg Systolic and 6.2 mmHg Diastolic on average (Systolic 134.2 ± 12 versus 142.6 ±14; Diastolic 83.7 ± 8.7 versus 89.9 ± 11).

Diabetes

  • The same group of 345 users measured their glucose levels with the Dario digital therapeutics platform for a period of six months or longer. 89% of study participants reported a confirmed diagnosis of prediabetes or Type 2 diabetes.
  • A reduction of 33% (5.4% versus 8.0%) in high readings (>250 mg/dL) and 67% (0.3% versus 0.9%) in severe events (>400 mg/dL) was observed at six months as compared to baseline.
  • A subset of 114 study subjects with elevated baseline blood glucose (>160 mg/dL) improved their average blood glucose by 14% (177 ±50 versus 207 ± 47 mg/dL) as compared to baseline.

Notably, the average age of participants in this study was 60.4 years, suggesting that the required use of technology by older individuals does not appear to be a significant barrier to engagement.

The paper concludes, “This observational study of a digital therapeutic platform for chronic disease demonstrates improved blood pressure at three months and glycemic control at six months compared to baseline. These findings suggest that digital therapeutics may help sustain behavioral change and play an important role in the management of diabetes and hypertension.”

Erez Raphael, Chief Executive Officer of Dario, stated, “We are excited about these positive results observed across hundreds of patients. We believe that this latest study adds to our growing body of clinical evidence, supporting the use of Dario’s platform to produce meaningful health improvements in patients who are trying to better manage their chronic conditions such as hypertension and diabetes. We believe that this information is not only helpful to the physicians who recommend use of our platform, but also to institutions like payers and self-insured employers who benefit from healthier members and employees in the form of reduced medical expenses. This value proposition is an important tool for attracting new clients in our Business-to-Business-to-Consumer (B2B2C) channel.”

About DarioHealth Corp.

DarioHealth Corp. (Nasdaq: DRIO) is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Our cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™ mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, visit http://dariohealth.com

Cautionary Note Regarding Forward-Looking Statements

This news release and the statements of representatives and partners of DarioHealth Corp. (the “Company”) related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “plan,” “project,” “potential,” “seek,” “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” or “continue” are intended to identify forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses its belief that the study adds to its growing body of clinical evidence, supporting the use of Dario’s platform to produce meaningful health improvements in patients who are trying to better manage their chronic conditions such as hypertension and diabetes, its belief that the information is not only helpful to the physicians who recommend use of its platform, but also to institutions like payers and self-insured employers who benefit from healthier members and employees in the form of reduced medical expenses and that the  value proposition is an important tool for attracting new clients in the its B2B2C channel. Readers are cautioned that certain important factors may affect the Company’s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company’s results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company’s actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company’s filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company’s commercial and regulatory plans for Dario™) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

DarioHealth Corporate Contact:
Claudia Levi
Content & Communications Manager
claudia@mydario.com
+1-347-767-4220

Media Inquiries:
Investor Relations Contact:
Chuck Padala
chuck@lifesciadvisors.com
+1 646-627-8390

Thursday, August 13th, 2020 Uncategorized Comments Off on $DRIO Announces Poster Presentation at the Virtual Association of Diabetes Care and Education Specialists 2020 Annual Conference

$PBIO Achieves Critical Milestone Through Award of Key Patent

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of a key U.S. patent entitled “Sample Preparation Devices and Methods.” According to the update, the new patent (U.S. 10,710,082) brings the company’s intellectual property (“IP”) estate up to a total of 25 issued patents. “We have many customers worldwide who routinely use our ‘PCT’ Micro-Pestle consumable in their research studies. These include Professor Phil Robinson and his team at the Children’s Medical Research Institute in Australia (processing 70,000 tumor samples, looking for prognostic and diagnostic markers in cancer) and Dr. Tiannan Guo and his team at Westlake University in China (studying thyroid cancer and COVID-19),” Pressure BioSciences’ Global Director of Sales and Marketing, Roxana McCloskey, said in the news release. “The PCT MP is also a critical part of the innovative laser microdissection tumor processing workflow developed by Dr. Tom Conrads of the Inova Health System in the U.S. This important new tumor processing method promises significant improvements in the clinical management of most solid tumor cancers. His novel workflow is the basis of our major co-marketing collaboration recently announced with Leica Microsystems (a Danaher Company). It is clear why we see this award of the PCT MP patent as a critical milestone in securing our pivotal intellectual property around the PCT system, and another important driver toward accelerated adoption of PCT in biological sample preparation markets. We expect to take full advantage of this opportunity and further boost our sales.”

To view the full press release, visit http://nnw.fm/jNfnD

About Pressure BioSciences, Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control biomolecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Wednesday, August 12th, 2020 Uncategorized Comments Off on $PBIO Achieves Critical Milestone Through Award of Key Patent

$NETE Electric Sports Car Manufacturing Coming to Washington State Via Proposed Merger Between NETE and Mullen Technologies

  • Mullen Technologies plans to open electric vehicle manufacturing facility in West Plains via proposed merger with NETE
  • Reverse merger will give Mullen stakeholders majority in newly formed company while accelerating process of taking Mullen public
  • Proposed 1.3 million square foot manufacturing facility is expected to create up to 4000 jobs by 2026

Mullen Technologies (“Mullen”) plans to bring electric vehicle (“EV”) manufacturing to West Plains, Washington through a proposed merger with Net Element (NASDAQ: NETE), a global technology group based in Miami that operates electronic payment services.

While still in its planning stages, the new EV manufacturing facility will comprise 1.3 million square feet of assembly and manufacturing space. A total of nearly 4000 jobs are expected to be created that include 55 at startup, 863 by 2026, and an additional 3,000 from the research and development of lithium-ion batteries through Mullen’s subsidiary company, Mullen Energy.

“We believe the timing of this merger is ideal for Mullen Technologies,” Mullen CEO David Michery said in recent statements (http://ibn.fm/b0ZoJ). “It comes on the preparation of our launch of the Dragonfly K50, which will be available in (the second quarter) of 2021 through our retail network in California and Arizona, and the development of a new EV model, the MX-05 Sport Utility Vehicle.”

Electric vehicle sales have grown substantially in recent years due to the falling prices of EV batteries, changes in fuel regulations and electric vehicle mandates in countries like China, which is expected to account for almost half (48%) of all passenger car sales in 2025, according to research by BloombergNEF (http://ibn.fm/LDvxf). Besides taking over most of the global passenger market by 2040, the report also predicts that electric vehicles will dominate municipal bus sales by 81% while taking 56% of light commercial vehicle sales and 31% of the medium commercial market.

Plans for the West Plains manufacturing plant are expected to accelerate following the merger, anticipated to occur in the third quarter of 2020. Pending stockholder and NASDAQ approval, the reverse merger between the companies will allow the stakeholders of Mullen Technologies, a privately held company, to acquire a majority of the stock in the newly formed company while accelerating the process of taking Mullen public and expanding its manufacturing operations.

NETE helps businesses of all sizes deliver innovative, virtually seamless payment systems with services that also include marketing solutions and business analytics.  Ranked by Deloitte in 2017 and 2018 as one of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies, NETE credits its progression to organic growth in its North America transactions segment.

For more information, visit the company’s website at www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Wednesday, August 12th, 2020 Uncategorized Comments Off on $NETE Electric Sports Car Manufacturing Coming to Washington State Via Proposed Merger Between NETE and Mullen Technologies

$UUUU Focused on Eliminating Debt, Growing Uranium Inventory

  • UUUU has eliminated half of the company’s debt, plans to be debt free by end of 2020
  • Company will have estimated $30 million of uranium & vanadium inventory — more if market prices rise — by end of 2020
  • Energy Fuels working toward producing rare earth elements in the U.S.

The largest uranium mining company in the United States, Energy Fuels (NYSE American: UUUU) (TSX: EFR) has eliminated one-half of its debt, plans to be debt free by the end of the year, and anticipates having $30 million of inventory value by the close of 2020 (http://ibn.fm/YpNEV). The company holds three of America’s key uranium production centers, including the White Mesa Mill, the only conventional uranium mill currently operating in the United States today.

“The strength of Energy Fuels’ balance sheet is unsurpassed in the global mid- and junior-uranium mining sectors today, including decreasing debt loads and increasing values on our product inventories,” said Energy Fuels president and CEO Mark S. Chalmers.

Uranium mining peaked in the 1980s with more than 250 operating mines, making the United States the world’s largest producer of energy fuels at that time. The situation has changed significantly since then. The U.S. now ranks 15th in the world and produces a mere 1% of the world’s uranium (http://ibn.fm/sEY6i) and less than 1% of U.S. requirements (http://ibn.fm/S120N).

Nuclear energy is clean energy, generating 20% of all electricity and more than 55% of the carbon-free, emission-free electricity in the country. Its continued use is vital in combating global climate change and air pollution, while also remaining affordable.

Energy Fuels is the top U.S. producer of uranium, supplying over one-third of the nation’s needs for the past 15 years. However, the country continues to import the majority of its uranium from foreign countries. Energy Fuels is working to change this by leading efforts in the 2018–2019 Uranium Section 232 (http://ibn.fm/OSTJQ), the Nuclear Fuel Working Group (http://ibn.fm/dWqGS), and the proposed creation of the new U.S. strategic uranium reserve (http://ibn.fm/1iMCl).

“No other comparable uranium miner to my knowledge has Energy Fuels’ inventory levels, and many are incurring significant debt to advance their development and exploration projects,” Chalmers stated. Decreasing debt has been a focus of Energy Fuels over the last several years. Being debt free by the end of 2020 protects the shareholders if the market does not meet expectations.

Energy Fuels anticipates 640,000 to 690,000 pounds of uranium inventory by the end of 2020; at the current value of uranium that is about a$22,000,000 value. Also, Chalmers shared that the company has 1,675,000 pounds of high-purity finished vanadium product, worth around $8.9 million at today’s prices. “I can think of no other comparable uranium miner anywhere in the world that has the potential to have over $30 million of inventory value at the end of 2020 — and possibly much more if uranium and/or vanadium prices improve,” he stated.

The company is looking into entering the rare earth elements (“REE”) space as well, which will incorporate the recycling of REE-bearing materials (http://ibn.fm/tgOqv). There is a lot of interest in rare earths at the current time, and Energy Fuels management believe the company is more advanced than other companies in the U.S. with respect to producing a salable rare earth concentrate (http://ibn.fm/xADbd).

Uranium recycling, vanadium production and the alternate-feed material recycling program have also created diverse cash-flow-generating opportunities for Energy Fuels that has played into the company’s ability to reduce debt while remaining environmentally responsible. The company’s alternate-feed material recycling program takes waste from non-mine sources and industrial activities and produces uranium, a clean-energy resource.

For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Wednesday, August 12th, 2020 Uncategorized Comments Off on $UUUU Focused on Eliminating Debt, Growing Uranium Inventory

$WTER 420 with CNW – Arizona Court Rules in Favor of Marijuana Ballot Initiative

Cannabis legalization activists in Arizona can finally breathe easy after a judge dismissed a lawsuit claiming that their recreational cannabis legalization measure was unfit for the November ballot. Last month, Arizonans for Health and Public Safety filed a lawsuit arguing that the measure wasn’t accurately described in the 100-word summary included in the petitions that voters signed. The group said that plenty of information was left out of the summary, denying voters all the information they needed to make an informed decision.

On Friday, Maricopa County Superior Court Judge rejected the claims that the 100 word summary on the initiative excluded the measure’s principal provisions. The judge, a Gov. Doug Ducey appointee, ruled that voters who signed the initiative had not been misled and that the measure could be on the ballot. “At 100 words, the summary also cannot include everything. That is why the full initiative must accompany the petition.”

He also chided foes of the initiative for suggesting that voters in Arizona might not be able to understand the implications of the measure’s provisions such as changing laws on advertising and altering regulations on driving under the influence of drugs. “This initiative is plain. It wants to legalize recreational marijuana. That is the principal provision,” wrote Smith in a 15-page ruling. “It is unlikely electors signing these petitions would be surprised by cascading effects of legalizing a formerly illegal substance.”

Arizonans for Health and Public Safety chairperson Lisa James, who filed the lawsuit with “eight concerned Arizona voters,” says an appeal is likely. Although the recreational cannabis legalization measure promises to direct substantial funds collected from sales tax towards community development, James says the summary failed to provide crucial details. This includes the fact that the measure would legalize more concentrated resins as well as cannabis flower.

She also claimed that the summary did not make it clear that if the measure became law, people could legally drive with metabolites of marijuana in their system, with the test being whether they were “impaired to the slightest degree.” However, according to Smith, that is irrelevant. He pointed out court cases that already say that medical marijuana patients with marijuana metabolites in their blood, evidence of earlier usage, cannot be convicted of driving under the influence of drugs unless they show evidence of impairment.

“An elector signing a petition to legalize recreational marijuana would likely be surprised if the initiative did not decriminalize driving with any amount of metabolite in one’s system.”

Industry watchers say the ruling in this case is likely to give the entire cannabis industry, including The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER), since it removes a possible barrier to giving people in Arizona a chance to decide whether marijuana should be legalized or not.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Wednesday, August 12th, 2020 Uncategorized Comments Off on $WTER 420 with CNW – Arizona Court Rules in Favor of Marijuana Ballot Initiative

$WTER Expands Channel Partner Distribution to Include Leading ‘DSD’ Provider – Mahaska

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused waters and CBD-infused products, today announced that its entire line of beverage offerings, including flavored waters, will be carried by Mahaska, a leading direct-store-deliver (“DSD”) provider in some of the major markets in the Midwest. “We are excited to announce the addition of Mahaska to our growing list of channel partners. As a best in class provider, the partnership opens an important regional market for us in our pursuit to be a national lifestyle brand across all major retail channels,” Richard Wright, president and CEO of The Alkaline Water Company, stated in the news release. “In addition to their strong presence in the supermarket and convenience store channel, Mahaska also serves an extensive network of vending providers and micro-markets, which could eventually open an exciting new growth market for us. This ties nicely with our major growth initiative of penetrating the hospitality space during our current fiscal year. With our superior taste profile and increasing consumer demand for healthier and eco-friendly options, we believe our brands will be a hit with their customers.”

To view the full press release, visit http://cnw.fm/ynnpc

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88(R) delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label “Clean Beverage.” Quickly being recognized as a growing lifestyle brand, Alkaline88(R) launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused(TM) flavored water is available in seven unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested full-spectrum hemp salves, balms, lotions, essential oils, and bath salts, along with broad-spectrum hemp beverage shots, powder packs, oil tinctures, capsules, and gummies. To purchase A88CBD(TM) products online, visit www.A88CBD.com. To learn more about The Alkaline Water Company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Wednesday, August 12th, 2020 Uncategorized Comments Off on $WTER Expands Channel Partner Distribution to Include Leading ‘DSD’ Provider – Mahaska

$GNPX Researchers Seek Answers Explaining Why Bones of Diabetics Are Fragile

People with type two diabetes are more likely to suffer broken bones than non-diabetic persons. As the number of people with diabetes rises, the skeletal brittleness in persons with type two diabetes is also increasing, and much is not known about the reasons responsible for this reality. The bone’s fragility is usually attributed to its density, but that is not the case with type two diabetes patients since they have normal bones. The puzzle is that they still suffer from fractures at a very high rate. However, researchers are on the verge of establishing the cause of these high fragilities in bones.

Are bones alive?

Like other living organs, bones are also alive. Bones are responsible for the structural integrity and protection of the body. Furthermore, red blood cells are produced within bones. The red blood cells are responsible for the production of valuable minerals such as phosphorus and calcium. When broken, bones can heal on their own or through medical interventions. However, bones are always in the state of constant repair through a process known as remodeling.

Wear and tear on bones happens daily due to the physical activities that people undertake. However, they are constantly repaired since this happens in micro-structures. The repairing process involves a breakdown in the minerals and proteins in the affected areas and replacing them with new and healthy proteins.

Crosslinking of Proteins

There are new proteins containing amino acids that are in natural reactions with sugar in the body. The result known as the non-enzymatic glycation occurs in tissues of the whole body, including bones. Non-enzymatic glycation creates a browning effect in proteins, creating small chemical links called crosslinks. It is developed in everyone’s body because everyone has some sugar levels in the body.

Though non-enzymatic crosslinks are naturally formed in the body, they are not good for your health. They harden the proteins they are attached to, inhibiting them from flexing as you take your daily activities. Bones require some forms of flexibility to prevent them from small fractures. However, non-enzymatic crosslinks weaken the bones and make them more fragile.

From research, it has been determined that people with type 2 diabetes have two worrying factors. One problem is that they have higher sugar levels in their body. The sugar level is catalyzed by the chemical reactions forming crosslinks. Therefore, a diabetic bone will have more crosslinks, which could explain why their bones are more brittle.

Another factor is that people with type 2 diabetes have a low bone remodeling process. With this, the cleaning ability of the crosslinks is reduced. It contributes a bigger number of crosslinks in the people with diabetes hence making their bones prone to breakage. Furthermore, crosslinks have added to other complications such as kidney damage, poor eyesight, and vascular damage in people with diabetes.

Reports from research

It has been found out that the hard and outer shell of bones had more crosslinks and weaker mechanical properties in people with diabetes than the normal persons. Research also reveals that when bones are subjected to more sugary environments, they produce more crosslinks, hence developing micro-fractures. However, the researchers are working on mechanisms that can break the crosslinks or prevent them from forming. They are hoping that it will work as a better medical remedy for diabetic patients. Analysts predict that entities like Genprex Inc. (NASDAQ: GNPX) are hoping that this results in a remedy to the brittle bones of diabetics as the health of everyone matters to all biomedical companies.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, August 12th, 2020 Uncategorized Comments Off on $GNPX Researchers Seek Answers Explaining Why Bones of Diabetics Are Fragile

$DRIO Announces Q2 Revenue, Overview of Key Company Highlights and Development

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has released a business update, including financial numbers and corporate achievements for the second quarter ended June 30, 2020. Highlights of the report include the company’s announcement of two Remote Patient Monitoring (“RPM”) agreements in the United States as well as an agreement with Williams Medical, which allowed Dario to enter the United Kingdom. In addition, the company reported Q2 revenues of $1.79 million, a 7.2% sequential increase from Q1 2020. “The COVID-19 pandemic has accelerated our ongoing transformation to a business-to-business-to-consumer (B2B2C) digital therapeutics leader,” said Dario CEO Erez Raphael in the release. “We advanced late-stage discussions with health plans and self-insured employers, who we believe recognize how our industry-leading user engagement and satisfaction metrics lead to improved health for their member and employee populations. Our pipeline continues to grow and mature, and although the normal sales cycle can be lengthy, we believe that we are poised to announce new and potentially transformational agreements in the next few weeks.”

To view the full press release, visit http://ibn.fm/U5RoZ

About DarioHealth Corp.

DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, the company empowers individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Dario’s cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario(TM) mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. For more information about the company, visit www.dariohealth.investorroom.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, August 12th, 2020 Uncategorized Comments Off on $DRIO Announces Q2 Revenue, Overview of Key Company Highlights and Development